<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">58609</article-id><article-id pub-id-type="doi">10.7554/eLife.58609</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Reshaping of bacterial molecular hydrogen metabolism contributes to the outgrowth of commensal <italic>E. coli</italic> during gut inflammation</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-187452"><name><surname>Hughes</surname><given-names>Elizabeth R</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4967-8819</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187453"><name><surname>Winter</surname><given-names>Maria G</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-237818"><name><surname>Alves da Silva</surname><given-names>Laice</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-237820"><name><surname>Muramatsu</surname><given-names>Matthew K</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-237821"><name><surname>Jimenez</surname><given-names>Angel G</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187454"><name><surname>Gillis</surname><given-names>Caroline C</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="pa1">†</xref><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187455"><name><surname>Spiga</surname><given-names>Luisella</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="pa2">‡</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187456"><name><surname>Chanin</surname><given-names>Rachael B</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-237819"><name><surname>Santos</surname><given-names>Renato L</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-187457"><name><surname>Zhu</surname><given-names>Wenhan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="pa2">‡</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-96225"><name><surname>Winter</surname><given-names>Sebastian E</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1532-9178</contrib-id><email>sebastian.winter@utsouthwestern.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution>Department of Microbiology, UT Southwestern</institution><addr-line><named-content content-type="city">Dallas</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Departamento de Clinica e Cirurgia Veterinarias, Escola de Veterinaria, Universidade Federal de Minas Gerais</institution><addr-line><named-content content-type="city">Belo Horizonte</named-content></addr-line><country>Brazil</country></aff><aff id="aff3"><label>3</label><institution>Department of Immunology, UT Southwestern</institution><addr-line><named-content content-type="city">Dallas</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Turnbaugh</surname><given-names>Peter</given-names></name><role>Reviewing Editor</role><aff><institution>University of California, San Francisco</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Garrett</surname><given-names>Wendy S</given-names></name><role>Senior Editor</role><aff><institution>Harvard T.H. Chan School of Public Health</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>†</label><p>Genentech Inc, South San Francisco, United States</p></fn><fn fn-type="present-address" id="pa2"><label>‡</label><p>Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, United States</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>04</day><month>06</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e58609</elocation-id><history><date date-type="received" iso-8601-date="2020-05-05"><day>05</day><month>05</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-05-20"><day>20</day><month>05</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Hughes et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Hughes et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-58609-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-58609-figures-v1.pdf"/><abstract><p>The composition of gut-associated microbial communities changes during intestinal inflammation, including an expansion of Enterobacteriaceae populations. The mechanisms underlying microbiota changes during inflammation are incompletely understood. Here, we analyzed previously published metagenomic datasets with a focus on microbial hydrogen metabolism. The bacterial genomes in the inflamed murine gut and in patients with inflammatory bowel disease contained more genes encoding predicted hydrogen-utilizing hydrogenases compared to communities found under non-inflamed conditions. To validate these findings, we investigated hydrogen metabolism of <italic>Escherichia coli,</italic> a representative Enterobacteriaceae, in mouse models of colitis. <italic>E. coli</italic> mutants lacking hydrogenase-1 and hydrogenase-2 displayed decreased fitness during colonization of the inflamed cecum and colon. Utilization of molecular hydrogen was in part dependent on respiration of inflammation-derived electron acceptors. This work highlights the contribution of hydrogenases to alterations of the gut microbiota in the context of non-infectious colitis.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>gut microbiota</kwd><kwd>dysbiosis</kwd><kwd>intestinal inflammation</kwd><kwd>hydrogenase</kwd><kwd>molecular hydrogen</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>E. coli</italic></kwd><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>AI118807</award-id><principal-award-recipient><name><surname>Winter</surname><given-names>Sebastian E</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>AI128151</award-id><principal-award-recipient><name><surname>Winter</surname><given-names>Sebastian E</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000928</institution-id><institution>Welch Foundation</institution></institution-wrap></funding-source><award-id>I-1969-20180324</award-id><principal-award-recipient><name><surname>Winter</surname><given-names>Sebastian E</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000861</institution-id><institution>Burroughs Wellcome Fund</institution></institution-wrap></funding-source><award-id>1017880</award-id><principal-award-recipient><name><surname>Winter</surname><given-names>Sebastian E</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000048</institution-id><institution>American Cancer Society</institution></institution-wrap></funding-source><award-id>RSG-17-048-01-MPC</award-id><principal-award-recipient><name><surname>Winter</surname><given-names>Sebastian E</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100011684</institution-id><institution>Crohn's and Colitis Foundation</institution></institution-wrap></funding-source><award-id>454921</award-id><principal-award-recipient><name><surname>Zhu</surname><given-names>Wenhan</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>AI007520</award-id><principal-award-recipient><name><surname>Hughes</surname><given-names>Elizabeth R</given-names></name><name><surname>Chanin</surname><given-names>Rachael B</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100008982</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>1000194723</award-id><principal-award-recipient><name><surname>Gillis</surname><given-names>Caroline C</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Bioinformatics analyses and experiments in mouse models reveal how <italic>Escherichia coli</italic> accesses the molecular hydrogen pool to boost colonization during acute colitis.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The mammalian distal gut is densely colonized by a community of bacteria, archaea, viruses, and eukaryotic microorganisms, collectively termed the gut microbiota. Under homeostatic conditions, the gut microbiota is dominated by obligate anaerobic bacteria in the Bacteroidetes and Firmicutes phyla (<xref ref-type="bibr" rid="bib17">Eckburg, 2005</xref>; <xref ref-type="bibr" rid="bib64">Moore and Holdeman, 1974</xref>). Members of the phyla Actinobacteria, Verrucomicrobia, and Proteobacteria constitute minor populations in the healthy gut microbiota. Obligate anaerobic bacteria successfully colonize the healthy gut due to their ability to degrade the available complex polysaccharides (<xref ref-type="bibr" rid="bib36">Kaoutari et al., 2013</xref>) (reviewed in <xref ref-type="bibr" rid="bib13">Cockburn and Koropatkin, 2016</xref>; <xref ref-type="bibr" rid="bib39">Koropatkin, 2012</xref>) and their ability to thrive in an anaerobic environment through fermentation (<xref ref-type="bibr" rid="bib29">Hartman, 2009</xref>; <xref ref-type="bibr" rid="bib34">Jalili-Firoozinezhad, 2019</xref>; <xref ref-type="bibr" rid="bib49">Litvak et al., 2018</xref>).</p><p>During intestinal inflammation, the composition of the gut microbiota changes compared to the homeostatic state. Microbial diversity decreases (<xref ref-type="bibr" rid="bib60">Manichanh, 2006</xref>; <xref ref-type="bibr" rid="bib63">Mirsepasi-Lauridsen, 2018</xref>), the prevalence of mucolytic bacteria in the mucosa increases (<xref ref-type="bibr" rid="bib74">Png, 2010</xref>), and populations of Enterobacteriaceae family members expand (<xref ref-type="bibr" rid="bib28">Haberman, 2014</xref>; <xref ref-type="bibr" rid="bib40">Kotlowski, 2007</xref>; <xref ref-type="bibr" rid="bib55">Lupp, 2007</xref>). Disease-associated changes in gut microbiota composition have been observed in patients with inflammatory bowel disease (IBD) (<xref ref-type="bibr" rid="bib21">Frank, 2007</xref>; <xref ref-type="bibr" rid="bib40">Kotlowski, 2007</xref>), enteric pathogen infection (<xref ref-type="bibr" rid="bib55">Lupp, 2007</xref>; <xref ref-type="bibr" rid="bib95">Stecher et al., 2007</xref>; <xref ref-type="bibr" rid="bib104">Wang et al., 2019</xref>), necrotizing enterocolitis (<xref ref-type="bibr" rid="bib56">Mai et al., 2011</xref>), and in animal models of colitis (<xref ref-type="bibr" rid="bib23">Garrett, 2007</xref>; <xref ref-type="bibr" rid="bib55">Lupp, 2007</xref>). Experiments in animal models suggest that mucosal host responses contribute to microbiota changes (<xref ref-type="bibr" rid="bib109">Winter and Bäumler, 2014</xref>; <xref ref-type="bibr" rid="bib108">Winter, 2013</xref>) and, conversely, microbial communities can instigate or perpetuate disease in the context of genetic susceptibility (<xref ref-type="bibr" rid="bib24">Garrett, 2010</xref>; <xref ref-type="bibr" rid="bib61">Manichanh, 2012</xref>; <xref ref-type="bibr" rid="bib114">Zhu, 2018</xref>).</p><p>In IBD patients, disease-associated changes in the microbiota composition, genetic coding capacity, and fecal metabolite concentrations not only correlate (<xref ref-type="bibr" rid="bib22">Franzosa, 2019</xref>), but the availability of certain metabolites impacts microbial community structure (<xref ref-type="bibr" rid="bib20">Fornelos, 2020</xref>; <xref ref-type="bibr" rid="bib31">Hughes, 2017</xref>). The inflammatory response produces reactive oxygen and nitrogen species, which when degraded in the gut lumen produce the electron acceptors tetrathionate, nitrate, and oxygen (<xref ref-type="bibr" rid="bib11">Chanin, 2020</xref>; <xref ref-type="bibr" rid="bib107">Winter, 2010</xref>; <xref ref-type="bibr" rid="bib108">Winter, 2013</xref>). Additionally, changes in colonocyte metabolism during inflammation also result in an increased availability of the electron acceptor oxygen (<xref ref-type="bibr" rid="bib10">Cevallos, 2019</xref>; <xref ref-type="bibr" rid="bib31">Hughes, 2017</xref>; <xref ref-type="bibr" rid="bib50">Litvak, 2019</xref>; <xref ref-type="bibr" rid="bib51">Lopez, 2016</xref>; <xref ref-type="bibr" rid="bib78">Rivera-Chavez, 2016</xref>). Findings from murine models of colitis suggest that the metabolic versatility of Enterobacteriaceae, particularly the ability to utilize a large repertoire of terminal electron acceptors, allows Enterobacteriaceae family members to thrive in the inflamed gut. Enterobacteriaceae utilize these inflammation-derived electron acceptors to perform anaerobic and aerobic respiration in the inflamed gut, thus gaining a fitness advantage over bacteria that rely on fermentation, a less energetically favorable metabolism. A functioning electron transport chain also enables utilization of poorly accessible carbon sources (<xref ref-type="bibr" rid="bib18">Faber et al., 2017</xref>; <xref ref-type="bibr" rid="bib20">Fornelos, 2020</xref>; <xref ref-type="bibr" rid="bib75">Price-Carter, 2001</xref>; <xref ref-type="bibr" rid="bib92">Spiga and Winter, 2019</xref>).</p><p>The role of respiratory dehydrogenases in inflammation-associated outgrowth of Enterobacteriaceae during non-infectious colitis is underexplored. A functioning electron transport chain requires oxidation of an electron donor by a respiratory dehydrogenase, shuttling liberated electrons to the quinone pool, and reduction of an electron acceptor via terminal reductases and oxidases. Reduction potentials and gene regulation determine which combinations of electron-donating and -accepting reactions occur under physiological conditions (<xref ref-type="bibr" rid="bib98">Unden et al., 2014</xref>). Formate dehydrogenases contribute to the expansion of Enterobacteriaceae in murine models of IBD (<xref ref-type="bibr" rid="bib31">Hughes, 2017</xref>). Under laboratory conditions, Enterobacteriaceae utilize several other molecules as electron donors, such as molecular hydrogen (H<sub>2</sub>). Therefore, we focused on investigating H<sub>2</sub> metabolism in the inflamed gut in the current study.</p><p>Hydrogenases are a diverse family of metalloenzymes that catalyze the oxidation and/or production of molecular hydrogen (<xref ref-type="bibr" rid="bib5">Benoit et al., 2020</xref>; <xref ref-type="bibr" rid="bib73">Pinske and Sawers, 2016</xref>). These enzymes are typically classified based on the metal content of the active site and their biochemical activity (<xref ref-type="bibr" rid="bib70">Peters, 1998</xref>; <xref ref-type="bibr" rid="bib85">Shima, 2008</xref>; <xref ref-type="bibr" rid="bib2">Anne, 1995</xref>). The active site of [NiFe]-hydrogenases contains nickel and iron, while the active site of [Fe]-hydrogenases and [FeFe]-hydrogenases includes one or two iron atoms, respectively. Based on their activity, hydrogenases can be further categorized into uptake, evolving, bidirectional, bifurcating, and sensory enzymes (<xref ref-type="bibr" rid="bib26">Greening, 2016</xref>; <xref ref-type="bibr" rid="bib99">Vignais and Billoud, 2007</xref>). Uptake hydrogenases convert H<sub>2</sub> to two protons and two electrons, with the two electrons often participating in an electron transport chain. Conversely, hydrogenases defined as evolving are responsible for production of H<sub>2</sub>. Bidirectional hydrogenases can produce or oxidize H<sub>2</sub> (reviewed in <xref ref-type="bibr" rid="bib96">Tamagnini, 2007</xref>). Bifurcating hydrogenases are enzymes involved in H<sub>2</sub> metabolism that use an exergonic reaction (e.g., oxidation of ferredoxin) to drive an endergonic reaction (e.g., oxidation of NADH) without an ion gradient (<xref ref-type="bibr" rid="bib48">Li, 2008</xref>; <xref ref-type="bibr" rid="bib83">Schut and Adams, 2009</xref>). Electron bifurcation was only recently demonstrated, yet the genomes of many anaerobes encode predicted bifurcating hydrogenases (<xref ref-type="bibr" rid="bib26">Greening, 2016</xref>; <xref ref-type="bibr" rid="bib83">Schut and Adams, 2009</xref>). Sensory hydrogenases detect changes in H<sub>2</sub> partial pressure and then activate regulatory cascades controlling expression of additional hydrogenases (<xref ref-type="bibr" rid="bib47">Lenz and Friedrich, 1998</xref>), but additional study is required to characterize the many putative sensory hydrogenases present in obligate anaerobes (<xref ref-type="bibr" rid="bib26">Greening, 2016</xref>).</p><p>Microbial H<sub>2</sub> metabolism in the inflamed gut is incompletely understood. Here, we mined previously published shotgun metagenomic sequencing datasets of human IBD patients and healthy controls (<xref ref-type="bibr" rid="bib22">Franzosa, 2019</xref>) as well as a mouse model of inflammation (<xref ref-type="bibr" rid="bib31">Hughes, 2017</xref>) with a focus on hydrogenases. Furthermore, we assessed whether hydrogenase activity enhances fitness of <italic>Escherichia coli</italic> in murine models of colitis. Our data suggest that utilization of molecular hydrogen contributes to the outgrowth of Enterobacteriaceae in the inflamed gut.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Shotgun metagenomic sequencing of the murine and human gut microbiota reveals changes in bacterial hydrogen metabolism coding capacity during intestinal inflammation</title><p>To investigate H<sub>2</sub> metabolism in the inflamed gut, we reanalyzed a previously published dataset of shotgun metagenomic sequencing of cecal microbiota from a murine colitis model (<xref ref-type="bibr" rid="bib31">Hughes, 2017</xref>). Cecal samples for metagenomic sequencing were collected from animals that were treated with dextran sulfate sodium (DSS) in the drinking water to induce epithelial injury and subsequent mucosal inflammation (<xref ref-type="bibr" rid="bib12">Chassaing, 2014</xref>) or mock treated (<xref ref-type="bibr" rid="bib31">Hughes, 2017</xref>). Comparing DSS-treated to mock-treated animals, we observed disparate abundance of various hydrogenases and their respective subunits, with enrichment of genes encoding some hydrogenases and depletion of others (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). This initial analysis suggested that H<sub>2</sub> metabolism might be altered during intestinal inflammation and motivated our subsequent studies.</p><p>Hydrogenase activity can be predicted based on primary sequence (<xref ref-type="bibr" rid="bib89">Søndergaard et al., 2016</xref>). The HydDB database has been widely utilized to classify hydrogenases (<xref ref-type="bibr" rid="bib16">Dong, 2020</xref>; <xref ref-type="bibr" rid="bib62">Mei, 2020</xref>; <xref ref-type="bibr" rid="bib68">Panwar, 2020</xref>; <xref ref-type="bibr" rid="bib69">Park et al., 2020</xref>; <xref ref-type="bibr" rid="bib72">Picone et al., 2020</xref>; <xref ref-type="bibr" rid="bib93">Stairs et al., 2020</xref>; <xref ref-type="bibr" rid="bib111">Wong, 2020</xref>; <xref ref-type="bibr" rid="bib113">Yu et al., 2020</xref>). We confirmed the reliability of gene annotations in the HydDB database using a simulated metagenomic dataset of hydrogenase-containing and hydrogenase-free genomes (see Materials and methods for details). To evaluate the abundance of hydrogenases with different activities in the murine colitis model, reads from the metagenomic sequencing experiment were aligned to the curated HydDB hydrogenase database and segregated based on predicted activity (<xref ref-type="bibr" rid="bib89">Søndergaard et al., 2016</xref>). The number of normalized reads that aligned to predicted bifurcating hydrogenases was virtually unchanged (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). The relative abundance of predicted bidirectional, evolving and sensory hydrogenases decreased modestly in the DSS-treated mice; however, this difference was not statistically significant (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Notably, reads aligned to predicted uptake hydrogenases, enzymes responsible for oxidation of H<sub>2</sub> via respiration, had a significantly higher abundance in DSS-treated mice than in mock-treated mice (p&lt;0.05) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Mapping of metagenomic sequencing data from murine cecal samples and human stool to bacterial hydrogenases.</title><p>(<bold>A</bold>) Shotgun metagenomic sequencing of mock or dextran sulfate sodium (DSS)-treated mice with endogenous Enterobacteriaceae (obtained from Charles River) was previously performed to generate the analyzed dataset (ENA accession number PRJEB15095; <xref ref-type="bibr" rid="bib31">Hughes, 2017</xref>). Reads were aligned to the HydDB hydrogenase database (<xref ref-type="bibr" rid="bib89">Søndergaard et al., 2016</xref>) and segregated based on predicted hydrogenase activity. Each symbol corresponds to the average number of normalized reads that map to a specific sequence in the mock or DSS-treated animals (six mice per group). Averages equal to zero were assigned a value of 0.05. (<bold>B, C</bold>) Analysis of a previously published metagenomic sequencing dataset from stool samples collected from non-inflammatory bowel disease (IBD) controls and patients with Crohn’s disease or ulcerative colitis (SRA BioProject number PRJNA400072; <xref ref-type="bibr" rid="bib22">Franzosa, 2019</xref>). Reads from non-IBD controls (55 samples) and patients with Crohn’s disease (87 samples) (<bold>B</bold>) or ulcerative colitis (76 samples) (<bold>C</bold>) were aligned to the HydDB hydrogenase database of predicted hydrogenase activities (<xref ref-type="bibr" rid="bib89">Søndergaard et al., 2016</xref>). Each symbol corresponds to the average number of normalized reads that map to a specific hydrogenase sequence. Averages equal to zero were assigned a value of 0.0005. Medians are labeled with a red solid line, and error bars correspond to interquartile ranges. Statistical significance was determined by Bonferroni-corrected Mann–Whitney U-test (*p&lt;0.05; **p&lt;0.01, ***p&lt;0.001; ns: not statistically significant). See also <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>, a <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>, <xref ref-type="supplementary-material" rid="fig1sdata2">Figure 1—source data 2</xref>, and <xref ref-type="supplementary-material" rid="fig1sdata3">Figure 1—source data 3</xref>.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Mapping of metagenomic sequencing of murine cecal content to hydrogenases.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58609-fig1-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Mapping of metagenomic sequencing of non-inflammatory bowel disease controls and patients with Crohn’s disease to hydrogenases.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58609-fig1-data2-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata3"><label>Figure 1—source data 3.</label><caption><title>Mapping of metagenomic sequencing of non-inflammatory bowel disease controls and patients with ulcerative colitis to hydrogenases.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-58609-fig1-data3-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58609-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Shotgun metagenomic sequence analysis of the cecal microbiota in the dextran sulfate sodium (DSS) colitis model.</title><p>Shotgun metagenomic sequencing of mock or DSS-treated mice with endogenous Enterobacteriaceae (from Charles River) was previously performed to generate the dataset used for analysis in this figure (ENA accession number PRJEB15095; <xref ref-type="bibr" rid="bib31">Hughes, 2017</xref>). Reads were assigned to functional categories based on the SEED algorithm (MEGAN5). Spuriously assigned reads (one read only present in one sample) were removed from this representation. The size of the circle charts is proportional to the number of reads. Each slice of the circle charts represents one animal, with mock-treated animals in yellow and DSS-treated animals in blue.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58609-fig1-figsupp1-v1.tif"/></fig></fig-group><p>We next sought to determine whether uptake hydrogenases are differentially abundant in IBD patients compared to healthy individuals. We analyzed a previously published shotgun metagenomic sequencing of stool samples from IBD patients and non-IBD controls (<xref ref-type="bibr" rid="bib22">Franzosa, 2019</xref>). The stool samples used in the study by Franzosa and colleagues were collected from individuals enrolled in PRISM the Prospective Registry in IBD Study at Massachusetts General Hospital; Boston, USA (<xref ref-type="bibr" rid="bib22">Franzosa, 2019</xref>) and in two studies in the Netherlands: LifeLines DEEP (<xref ref-type="bibr" rid="bib97">Tigchelaar et al., 2015</xref>) and NLIBD (<xref ref-type="bibr" rid="bib22">Franzosa, 2019</xref>). We aligned metagenomic reads from the aforementioned cohorts to the HydDB hydrogenase database (<xref ref-type="bibr" rid="bib89">Søndergaard et al., 2016</xref>) to assess the abundance of genes encoding hydrogenases with predicted functions (<xref ref-type="fig" rid="fig1">Figure 1B–C</xref>). Mirroring our observations in the murine model of colitis, we detected a significantly higher abundance of predicted uptake hydrogenases in patients with IBD than non-IBD controls (p&lt;0.001 for patients with Crohn’s disease; p&lt;0.01 for patients with ulcerative colitis; <xref ref-type="fig" rid="fig1">Figure 1B–C</xref>). Reads that aligned to predicted bifurcating or sensory hydrogenases were slightly more abundant in the ulcerative colitis patients (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), but virtually unchanged in the Crohn’s disease patients (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). In contrast with our findings in the murine gut (<xref ref-type="fig" rid="fig1">Figure 1A</xref>), there was a significantly higher abundance of reads that aligned to predicted evolving hydrogenases in IBD samples (<xref ref-type="fig" rid="fig1">Figure 1B–C</xref>). These data suggest that microbial H<sub>2</sub> metabolism is altered in human IBD patients and in a mouse model of inflammation. Furthermore, the increase in relative abundance of predicted uptake hydrogenase genes during gut inflammation suggests that organisms that encode H<sub>2</sub>-utilizing hydrogenases may have a fitness advantage during intestinal inflammation.</p></sec><sec id="s2-2"><title>Hydrogen utilization promotes fitness of <italic>E. coli</italic> in the inflamed gut</title><p>To investigate whether changes in H<sub>2</sub> metabolism contribute to the inflammation-associated expansion of Enterobacteriaceae populations, we focused on commensal <italic>E. coli</italic> as a representative organism. The <italic>E. coli</italic> K-12 genome encodes four hydrogenases: two H<sub>2</sub>-oxidizing enzymes, hydrogenase-1 (Hyd-1) and hydrogenase-2 (Hyd-2), and two H<sub>2</sub>-evolving enzymes (hydrogenase-3 and hydrogenase-4). Hyd-1 and Hyd-2 are encoded by the <italic>hya</italic> and <italic>hyb</italic> operons, respectively (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). We therefore hypothesized that Hyd-1 and Hyd-2 might provide a fitness advantage to Enterobacteriaceae in the inflamed gut. To determine the contribution of H<sub>2</sub> utilization, we used two commensal <italic>E. coli</italic> strains. Nissle 1917 (EcN) was originally isolated from a human (<xref ref-type="bibr" rid="bib27">Grozdanov, 2004</xref>) and MP1 is a mouse isolate (<xref ref-type="bibr" rid="bib45">Lasaro, 2014</xref>). We initially generated isogenic mutants lacking Hyd-1 and Hyd-2 activity (Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). As expected, inactivation of Hyd-1 and Hyd-2 activity had no discernible effect on growth of EcN under standard, aerobic laboratory conditions (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). We next co-cultured the EcN wild-type and an isogenic Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant under anaerobic conditions in the presence of 5% molecular hydrogen with mucin as a carbon source (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). After 18 hr, the ratio of the two strains, corrected by the corresponding ratio in the inoculum, was determined (competitive index). Consistent with previous reports (<xref ref-type="bibr" rid="bib112">Yamamoto and Ishimoto, 1978</xref>), H<sub>2</sub> utilization only provided a growth advantage when an external electron acceptor, such as fumarate, was added to the media. The Hyd-2 enzyme is primarily responsible for enhancing growth under these culture conditions since a mutant lacking both Hyd-1 and Hyd-2 (Δ<italic>hya</italic> Δ<italic>hyb</italic>) was outcompeted by a strain only lacking Hyd-1 (Δ<italic>hya</italic>); conversely, a Δ<italic>hyb</italic> and a Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant were equally fit in this assay (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). Genetic complementation restored the phenotype of Hyd-2-deficiency (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Hydrogenases provide a competitive fitness advantage for <italic>E</italic>. <italic>coli</italic> during acute colitis.</title><p>(<bold>A</bold>) Schematic representation of the hydrogenase-1 and hydrogenase-2 encoding gene loci in <italic>E. coli</italic> Nissle 1917 (EcN) and MP1. The DNA regions that were removed from the Δ<italic>hya</italic> and Δ<italic>hyb</italic> mutants in EcN and MP1 are indicated in black (EcN) and brown (MP1), respectively. (<bold>B–D</bold>) Groups of wild-type (WT) male (<bold>C, D</bold>) and female (<bold>D</bold>) C57BL/6 mice devoid of native Enterobacteriaceae were treated with 3% dextran sulfate sodium (DSS) in the drinking water. Mice were orally inoculated with a 1:1 ratio of the WT strain and an isogenic Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant on day 4 of DSS treatment. (<bold>B</bold>) Schematic representation of the colitis model. (<bold>C, D</bold>) Intestinal content was collected on day 9 to determine the abundance of the EcN (<bold>C</bold>) or MP1 (<bold>D</bold>) WT strain (black bars) or isogenic Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant (gray bars). The competitive index (CI) is indicated above each set of bars. Each symbol corresponds to one mouse. Bars represent geometric means ± 95% confidence intervals. Statistical significance was determined by paired Student’s <italic>t</italic>-test of the log-transformed data (**p&lt;0.01; ***p&lt;0.001). See also <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref> and 2.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58609-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>In vitro analysis of <italic>E</italic>. <italic>coli</italic> wild-type (WT) and hydrogenase-deficient mutant strains.</title><p>(<bold>A</bold>) Aerobic growth of the indicated <italic>E. coli</italic> Nissle 1917 (EcN) strains in M9 minimal media supplemented with glucose. Data points correspond to averages ± standard deviation of three biological replicates. (<bold>B, C</bold>) Mucin broth alone or supplemented with the electron acceptors fumarate (25 mM) or nitrate (40 mM) was inoculated with an equal mixture of the indicated EcN strains. Cultures were incubated anaerobically, in the presence of 5% H<sub>2</sub>, for 18 hr, and the competitive index was determined. Each symbol corresponds to a biological replicate. Bars represent geometric means ± 95% confidence intervals. Statistical significance was determined for each set of competition experiments using ANOVA with Dunnett’s multiple comparisons test of the log-transformed data (**p&lt;0.01, ***p&lt;0.001; ns: not statistically significant).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58609-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Assessment of bacterial fitness in the murine intestinal lumen.</title><p>(<bold>A, B</bold>) Wild-type (WT) male C57BL/6 mice received 3% dextran sulfate sodium (DSS) in the drinking water to induce colitis. On day 4 of DSS treatment, mice were orally inoculated with a 1:1 ratio of WT <italic>E. coli</italic> MP1 carrying the pWSK129 plasmid (Kan<sup>r</sup>) or the pWSK29 (Amp<sup>r</sup>/Carb<sup>r</sup>) plasmid. After 5 days of colonization, mice were euthanized. (<bold>A</bold>) Mouse body weights. Data points represent geometric means ± standard error. (<bold>B</bold>) At the end of the experiment, the abundance of the two <italic>E. coli</italic> strains was determined by plating intestinal content on LB agar containing Kan or Carb. The competitive index (CI) is displayed above each set of bars. Each symbol corresponds to one mouse. Bars represent geometric means ± 95% confidence intervals. Statistical significance was determined by paired Student’s <italic>t</italic>-test of the log-transformed data (ns: not statistically significant). (<bold>C, D</bold>) Mouse body weights were measured for the experiments described in <xref ref-type="fig" rid="fig2">Figure 2C and D</xref>. Briefly, groups of WT C57BL/6 mice were treated with 3% DSS in the drinking water and orally inoculated with a 1:1 ratio of the WT strain and an isogenic Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant. Mice were colonized with <italic>E. coli</italic> Nissle 1917 (EcN) strains (<bold>C</bold>) or with MP1 strains (<bold>D</bold>). Data points represent geometric means ± standard error.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58609-fig2-figsupp2-v1.tif"/></fig></fig-group><p>We next examined whether Hyd-1 and Hyd-2 contribute to <italic>E. coli</italic> colonization of the murine large intestine. C57BL/6 mice acquired from the Jackson Laboratory (Bar Harbor, ME) do not have any detectable endogenous Enterobacteriaceae (data not shown), which facilitates engraftment and recovery of exogenously introduced <italic>E. coli</italic>. To facilitate recovery of exogenously introduced <italic>E. coli</italic> strains, the wild-type and mutant strains were marked with low-copy number plasmids (<xref ref-type="bibr" rid="bib102">Wang and Kushner, 1991</xref>; <xref ref-type="bibr" rid="bib108">Winter, 2013</xref>; <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A,B</xref>). Groups of mice were given DSS in the drinking water to induce colitis (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). On day 4, coinciding with disease onset as determined by body weight loss (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2C,D</xref>), mice were orally inoculated with an equal mixture of the respective wild-type strain and the isogenic Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant strain. Five days after colonization, the abundance of each strain in the colonic and cecal content was determined and the competitive index was calculated (<xref ref-type="fig" rid="fig2">Figure 2C,D</xref>). The EcN wild-type strain outcompeted the Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant in the colonic and cecal content (12-fold in the colon and 5.8-fold in the cecum; <xref ref-type="fig" rid="fig2">Figure 2C</xref>), while the MP1 wild-type strain was recovered in significantly higher numbers than the uptake hydrogenase-deficient mutant in the colonic and cecal content (25-fold and 22-fold, respectively; <xref ref-type="fig" rid="fig2">Figure 2D</xref>).</p><p>We also determined whether <italic>hya</italic> and <italic>hyb</italic> promote gut colonization in the absence of a close competitor (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Mice were treated with DSS and colonized with either the EcN wild-type strain or an isogenic Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant and colonization of the large intestine content assessed after 5 days (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Consistent with our observations in the competitive colonization experiments, the wild-type strain was more abundant in the colonic and cecal content than the uptake hydrogenase-deficient mutant (4.7-fold and 5.1-fold, respectively; <xref ref-type="fig" rid="fig3">Figure 3B</xref>). Collectively, these results suggest that H<sub>2</sub> utilization via Hyd-1 and Hyd-2 enhances fitness and contributes to <italic>E. coli</italic> colonization of the inflamed large intestine.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Hydrogenases enhance growth of <italic>E. coli</italic> in a colitis model.</title><p>Wild-type (WT) female C57BL/6 mice were treated with 3% dextran sulfate sodium (DSS) in the drinking water to induce colitis. On day 4 of DSS treatment, mice were orally inoculated with either the WT <italic>E. coli</italic> Nissle 1917 (EcN) strain or the isogenic Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant strain. (<bold>A</bold>) Schematic representation of the experiment. (<bold>B</bold>) Intestinal content was collected 9 days later to determine the abundance of <italic>E. coli</italic> in the colon and cecum. Each symbol corresponds to the <italic>E. coli</italic> bacterial abundance in one mouse. Bars represent geometric means ± 95% confidence intervals. Black bars, WT. Gray bars, Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant. Statistical significance was determined by unpaired Student’s <italic>t</italic>-test of the log-transformed data (*p&lt;0.05; **p&lt;0.01).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58609-fig3-v1.tif"/></fig></sec><sec id="s2-3"><title>Hydrogen utilization contributes to the expansion of <italic>E. coli</italic> during intestinal inflammation</title><p>We next wanted to assess whether H<sub>2</sub>-utilizing hydrogenases contributed to inflammation-associated expansion of <italic>E. coli</italic> populations, where C57BL/6 mice are colonized with <italic>E. coli</italic> prior to induction of colitis. We chose to use the MP1 strain for this experiment as it is a mouse commensal isolate that colonizes the mouse intestinal tract in the absence of inflammation (<xref ref-type="bibr" rid="bib45">Lasaro, 2014</xref>). Groups of mice were orally inoculated with a mixture of the MP1 wild-type strain and the Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant. One group received DSS treatment, while the other group was mock-treated (no inflammation) (<xref ref-type="fig" rid="fig4">Figure 4A–C</xref>). Under homeostatic conditions, the wild-type strain and the Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant colonized the colon and cecum at low levels (<xref ref-type="fig" rid="fig4">Figure 4D and E</xref>). However, the wild-type strain had a marked fitness advantage over the Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant in the DSS-treated mice (<xref ref-type="fig" rid="fig4">Figure 4D and E</xref>). Of note, the MP1 wild-type strain outcompeted the Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant to a higher degree in this experiment than in the previous experiment in which <italic>E. coli</italic> strains were introduced at the onset of inflammation (<xref ref-type="fig" rid="fig2">Figure 2D</xref>).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Hydrogenases contribute to expansion of <italic>E</italic>. <italic>coli</italic> in the inflamed gut.</title><p>Groups of wild-type (WT) male C57BL/6 mice were orally inoculated with a 1:1 ratio of the <italic>E. coli</italic> MP1 WT strain and the isogenic Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant. On the same day as the oral inoculation, mice received water or 3% dextran sulfate sodium (DSS) in the drinking water. (<bold>A</bold>) Schematic representation of experiment. (<bold>B</bold>) Mouse body weights. Data points represent geometric means ± standard error (mock-treated, black circles; DSS-treated, gray squares). (<bold>C</bold>) Hematoxylin and eosin-stained colonic and cecal sections were scored by a veterinary pathologist for submucosal edema (light gray bars), immune infiltration by polymorphonuclear cells (PMN) (dark gray bars), epithelial damage (medium gray bars), and exudate (black bars). Bars for each histopathology category correspond to the average per group. (<bold>D, E</bold>) The abundance of each strain was determined in the colonic (<bold>D</bold>) and cecal (<bold>E</bold>) content (WT strain, black bars; Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant, gray bars). The competitive index (CI) is indicated above the sets of DSS-treated bars. Each symbol corresponds to one mouse. Dashed line corresponds to the limit of detection. Samples with values below the limit of detection were assigned a value of 10 CFU/g. Bars represent geometric means ± 95% confidence intervals. Statistical significance was determined by paired Student’s <italic>t</italic>-test of the log-transformed data (***p&lt;0.001).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58609-fig4-v1.tif"/></fig><p>To better understand <italic>E. coli</italic> H<sub>2</sub> metabolism in the context of gut inflammation, we colonized groups of DSS-treated mice with a mixture of the MP1 wild-type and the Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant and acquired samples in 2-day intervals (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Disease severity and intestinal inflammation developed over time, as quantified by loss of body weight (<xref ref-type="fig" rid="fig5">Figure 5A</xref>), diminished colon length (<xref ref-type="fig" rid="fig5">Figure 5B</xref>), increased mRNA levels of pro-inflammatory cytokines (<italic>Cxcl1</italic> and <italic>Tnfa</italic>) (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A,B</xref>), and manifestation of pathological changes (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2A,B</xref>). At the same time as inflammation developed, the magnitude of the phenotype conferred by H<sub>2</sub> utilization in <italic>E. coli</italic> increased and stayed constant at later time points (<xref ref-type="fig" rid="fig5">Figure 5C–D</xref>). Notably, colon length, a sensitive measure of colitis, was inversely correlated with the competitive fitness advantage of the wild-type strain over the Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3A,B</xref>). In the absence of inflammation, the fitness of the wild-type strain and the Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant were somewhat comparable at 3 days (<xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4</xref>) and 9 days and after initial colonization (<xref ref-type="fig" rid="fig4">Figure 4D–E</xref>). Taken together, we conclude that Hyd-1 and Hyd-2 provide a notable fitness advantage to <italic>E. coli</italic> during the inflammation-associated expansion of the Enterobacteriaceae population.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Hydrogenase-dependent fitness of <italic>E</italic>. <italic>coli</italic> correlates with intestinal inflammation.</title><p>Groups of wild-type (WT) male (2–3 per group) and female (3–4 per group) C57BL/6 mice were orally inoculated with a 1:1 ratio of the <italic>E. coli</italic> MP1 WT strain and the isogenic Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant. On the same day as the oral inoculation, mice received 3% dextran sulfate sodium in the drinking water. Groups of mice were euthanized on days 1, 3, 5, 7, and 9 after inoculation. (<bold>A</bold>) Mouse body weights. Data points represent geometric means ± standard error. (<bold>B</bold>) Colon lengths. Each symbol corresponds to data from one mouse. Bars represent geometric means ± 95% confidence intervals. (<bold>C, D</bold>) The competitive indices of the WT strain and the Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant in the colonic (<bold>C</bold>) and cecal (<bold>D</bold>) contents were determined. Each symbol corresponds to one mouse. Bars represent geometric means ± 95% confidence intervals. Statistical significance was determined by the Kruskal–Wallis test with Dunn’s <italic>post hoc</italic> multiple analyses test (*p&lt;0.05; **p&lt;0.01; ***p&lt;0.001). See also <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplements 1</xref>–<xref ref-type="fig" rid="fig5s4">4</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58609-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Expression of pro-inflammatory markers in time-course experiment.</title><p>For the experiment described in <xref ref-type="fig" rid="fig5">Figure 5</xref>, mRNA levels of pro-inflammatory markers in cecal and colonic tissue were determined by RT-qPCR. Levels of Cxcl1 (KC), TNF-α, and iNOS, encoded by <italic>Cxcl1</italic> (<bold>A</bold>), <italic>Tnfa</italic> (<bold>B</bold>), and <italic>Nos2</italic> (<bold>C</bold>), respectively, were determined. Briefly, groups of wild-type (WT) C57BL/6 mice were orally inoculated with a 1:1 ratio of the <italic>E. coli</italic> MP1 WT strain and the isogenic Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant and treated with 3% dextran sulfate sodium in the drinking water. Tissue samples were collected from euthanized mice 1, 3, 5, 7, and 9 days post inoculation. Tissue samples from untreated healthy WT male (N = 2) and female (N = 2) C57BL/6 mice were also collected and analyzed (mock). Samples lacking detectable transcripts were excluded from analysis. Each symbol corresponds to one mouse. Bars represent geometric means ± 95% confidence intervals. Statistical significance was determined by a one-way ANOVA with Dunnett’s multiple comparisons (*p&lt;0.05; **p&lt;0.01; ***p&lt;0.001).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58609-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Development of pathological lesions during dextran sulfate sodium treatment.</title><p>(<bold>A, B</bold>) Hematoxylin and eosin-stained colonic (<bold>A</bold>) and cecal (<bold>B</bold>) tissue, obtained from the experiment shown in <xref ref-type="fig" rid="fig5">Figure 5</xref>, were scored by a veterinary pathologist for submucosal edema (light gray bars), immune infiltration by polymorphonuclear cells (PMNs) (dark gray bars), epithelial damage (medium gray bars), and exudate (black bars). Tissue samples from the healthy C57BL/6 mice shown in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref> were also collected and analyzed (mock). Bars for each histopathology category correspond to the average per group.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58609-fig5-figsupp2-v1.tif"/></fig><fig id="fig5s3" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 3.</label><caption><title>Hydrogenase-dependent competitive fitness of <italic>E</italic>. <italic>coli</italic> correlates with colon length.</title><p>(<bold>A, B</bold>) The competitive indices in the cecal (<bold>A</bold>) and colonic (<bold>B</bold>) content of the mice shown in <xref ref-type="fig" rid="fig5">Figure 5</xref> were compared to the respective colon lengths of each mouse. Each symbol corresponds to one mouse. Statistical correlation was determined via Spearman correlation.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58609-fig5-figsupp3-v1.tif"/></fig><fig id="fig5s4" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 4.</label><caption><title>Hydrogenases do not provide a competitive fitness advantage to <italic>E</italic>. <italic>coli</italic> in healthy mice colonized for 3 days.</title><p>Wild-type (WT) male and female C57BL/6 mice were orally inoculated with a 1:1 ratio of the <italic>E. coli</italic> MP1 WT strain and the isogenic Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant. (<bold>A</bold>) Schematic representation of experiment. (<bold>B</bold>) The abundance of each strain was determined in the colonic and cecal content (WT strain, WT, black bars; Δ<italic>hya</italic> Δ<italic>hyb</italic> strain, gray bars) 3 days after inoculation. Each symbol corresponds to one mouse. Dashed line corresponds to the limit of detection. Samples with values below the limit of detection were assigned a value of 10 CFU/g. Bars represent geometric means ± 95% confidence intervals.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58609-fig5-figsupp4-v1.tif"/></fig></fig-group></sec><sec id="s2-4"><title>Hyd-1 and Hyd-2 enhance fitness of <italic>E. coli</italic> in the piroxicam-accelerated <italic>Il10</italic><sup>-/-</sup> colitis model</title><p>DSS promotes mucosal inflammation by causing epithelial injury (<xref ref-type="bibr" rid="bib14">Cooper, 1993</xref>). To determine whether H<sub>2</sub> utilization also provides a fitness advantage to <italic>E. coli</italic> in a colitis model in which inflammation was induced by a different mechanism, we used a genetic model of colitis. Conventionally raised mice deficient for the anti-inflammatory cytokine IL-10 (encoded by <italic>Il10</italic>) develop colitis spontaneously (<xref ref-type="bibr" rid="bib41">Kuhn, 1993</xref>; <xref ref-type="bibr" rid="bib84">Sellon, 1998</xref>). This process can be accelerated via oral administration of piroxicam, a nonselective nonsteroidal anti-inflammatory drug (<xref ref-type="bibr" rid="bib6">Berg et al., 2002</xref>). Groups of <italic>Il10</italic><sup>-/-</sup> mice were fed piroxicam-fortified chow instead of regular chow over the course of the experiment and were orally inoculated with an equal mixture of wild-type <italic>E. coli</italic> EcN or MP1 strain and the respective isogenic Δ<italic>hya</italic> Δ<italic>hyb</italic> mutants 2 days after the start of the piroxicam treatment (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). We used three different experimental designs in which we varied the mouse genetic background, piroxicam dose, duration of the experiment, and <italic>E. coli</italic> strain used (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Mice exhibited differential susceptibility and weight loss was most prominent in the C57BL/6 background (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). Importantly, the wild-type <italic>E. coli</italic> strains significantly outcompeted the Δ<italic>hya</italic> Δ<italic>hyb</italic> mutants, regardless of the experimental setting (<xref ref-type="fig" rid="fig6">Figure 6C–E</xref>). Taken together, H<sub>2</sub> utilization provides a fitness advantage to <italic>E. coli</italic> in both chemically induced and genetically induced models of murine colitis.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Hydrogenases promote fitness of <italic>E</italic>. <italic>coli</italic> in piroxicam-accelerated <italic>Il10</italic><sup>-/-</sup> colitis models.</title><p>Groups of <italic>Il10</italic><sup>-/-</sup> C57BL/6 and <italic>Il10</italic><sup>-/-</sup> BALB/c mice received piroxicam-fortified diet. Mice were orally inoculated with a 1:1 ratio of the <italic>E. coli</italic> wild-type (WT) strain and the isogenic Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant on day 2 of piroxicam treatment. Nissle 1917 (EcN) and MP1 strains of <italic>E. coli</italic> were used. (<bold>A</bold>) Schematic representations of colitis models. (<bold>B</bold>) Body weights. Data points represent geometric means ± standard error (EcN-colonized <italic>Il10</italic><sup>-/-</sup> C57BL/6, white triangles; EcN-colonized <italic>Il10</italic><sup>-/-</sup> BALB/c, black circles; MP1-colonized <italic>Il10</italic><sup>-/-</sup> BALB/c, gray squares). Four mice were excluded from analysis of the MP1-colonized <italic>Il10</italic><sup>-/-</sup> BALB/c mice on days 11–12 as the body weights of those mice were not available. (<bold>C</bold>) Abundance of the EcN WT strain and the Δ<italic>hya</italic> Δ<italic>hyb</italic> strain in the intestinal content of piroxicam-treated <italic>Il10</italic><sup>-/-</sup> male C57BL/6. (<bold>D</bold>) Abundance of the EcN WT strain and the Δ<italic>hya</italic> Δ<italic>hyb</italic> strain in the intestinal content of piroxicam-treated <italic>Il10</italic><sup>-/-</sup> male BALB/c mice. (<bold>E</bold>) Abundance of the MP1 WT strain and the Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant in the intestinal content of piroxicam-treated <italic>Il10</italic><sup>-/-</sup> male and female BALB/c. (<bold>C–E</bold>) CI: competitive index. Each symbol corresponds to one mouse. Dashed line corresponds to the limit of detection. Samples with values below the limit of detection were assigned a value of 10 CFU/g. Bars represent geometric means ± 95% confidence intervals. Statistical significance was determined by paired Student’s <italic>t</italic>-test of the log-transformed data (*p&lt;0.05; ***p&lt;0.001).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58609-fig6-v1.tif"/></fig></sec><sec id="s2-5"><title>Hydrogen utilization in the inflamed gut partially depends on fumarate, nitrate, and oxygen respiration</title><p>Hyd-1 and Hyd-2 are both H<sub>2</sub>-utilizing, membrane-bound hydrogenases that transfer electrons from H<sub>2</sub> oxidation to the electron transport chain. In vitro, hydrogen oxidation is coupled to fumarate reduction and nitrate respiration (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>; <xref ref-type="bibr" rid="bib46">Laurinavichene and Tsygankov, 2001</xref>; <xref ref-type="bibr" rid="bib112">Yamamoto and Ishimoto, 1978</xref>). The redox potential of the nitrate/nitrite couple is more favorable than that of fumarate/succinate. As such, nitrate is the preferred electron acceptor for H<sub>2</sub> utilization in <italic>E. coli</italic> (<xref ref-type="fig" rid="fig7">Figure 7A</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Utilization of various electron acceptors facilitates hydrogenase-dependent competitive outgrowth of <italic>E. coli</italic>.</title><p>(<bold>A</bold>) Mucin broth supplemented with or without the electron acceptors fumarate (25 mM) and nitrate (0.4 mM or 40 mM) was inoculated with an equal mixture of the indicated EcN strains. Cultures were incubated anaerobically, in the presence of 5% H<sub>2</sub>, for 18 hr and the competitive index was determined. Each symbol corresponds to a biological replicate. Bars represent geometric means ± 95% confidence intervals. WT: wild-type strain; NR: <italic>narG narZ napA</italic> mutant. Statistical significance was determined for the indicated comparisons using ANOVA with Sidak’s multiple comparisons test of the log-transformed data (**p&lt;0.01, ***p&lt;0.001; ns: not statistically significant). (<bold>B, C</bold>) Groups of WT male and female C57BL/6 mice were treated with 3% dextran sulfate sodium (DSS) in the drinking water. Mice were orally inoculated with a 1:1 ratio of the indicated <italic>E. coli</italic> Nissle 1917 (EcN) strains on day 4 of DSS treatment. Colonic (<bold>B</bold>) and cecal (<bold>C</bold>) content was collected after 9 days of DSS treatment to determine the competitive indices. Each symbol corresponds to one mouse. Bars represent geometric means ± 95% confidence intervals. Statistical significance was determined by the Kruskal–Wallis test with Dunn’s <italic>post hoc</italic> multiple analyses test (*p&lt;0.05; **p&lt;0.01; ***p&lt;0.001). See also <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58609-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Hydrogenases confer a competitive fitness advantage to <italic>E</italic>. <italic>coli</italic> during colitis, independent of mouse sex.</title><p>The same data as shown in <xref ref-type="fig" rid="fig7">Figure 7B–C</xref> (wild-type [WT] vs. Δ<italic>hya</italic> Δ<italic>hyb</italic>) is shown here, stratified based on mouse sex. Briefly, WT C57BL/6 mice were treated with 3% dextran sulfate sodium (DSS) in the drinking water and orally inoculated with a 1:1 ratio of the <italic>E. coli</italic> Nissle 1917 (EcN) WT strain and the Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant on day 4 of DSS treatment. Colonic and cecal content was collected after 9 days of DSS treatment to determine the competitive indices. Each symbol corresponds to one mouse. Bars represent geometric means ± 95% confidence intervals. Statistical significance was determined by unpaired Student’s <italic>t</italic>-test of the log-transformed data (ns: not statistically significant).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58609-fig7-figsupp1-v1.tif"/></fig></fig-group><p>During gut inflammation, levels of inducible nitric oxide synthase (<italic>Nos2</italic>) increase (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>; <xref ref-type="bibr" rid="bib87">Singer, 1996</xref>; <xref ref-type="bibr" rid="bib108">Winter, 2013</xref>) enabling nitrate respiration, which supports growth of Enterobacteriaceae family members (<xref ref-type="bibr" rid="bib31">Hughes, 2017</xref>; <xref ref-type="bibr" rid="bib108">Winter, 2013</xref>). In addition, <italic>E. coli</italic> respires oxygen using the cytochrome bd-II oxidase enzyme (AppBCX) (<xref ref-type="bibr" rid="bib11">Chanin, 2020</xref>). We therefore examined whether H<sub>2</sub> utilization in the murine gut was dependent on fumarate reductase, cytochrome bd-II oxidase, or nitrate reductase activity. We assessed the fitness advantage provided by Hyd-1 and Hyd-2 in the presence (wild-type strain vs. a Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant) and absence of a specific reductase (e.g., Δ<italic>frd</italic> mutant vs. Δ<italic>frd</italic> Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant) in the DSS colitis model (<xref ref-type="fig" rid="fig7">Figure 7B–C</xref>). The competitive advantage conferred by Hyd-1 and Hyd-2 was significantly reduced in the absence of fumarate reductase, cytochrome bd-II oxidase, or nitrate reductase activity. Consistent with the idea that all three electron acceptors contribute to the H<sub>2</sub> utilization phenotype, inactivation of each reductase did not completely abolish the phenotype (<xref ref-type="fig" rid="fig7">Figure 7B–C</xref>).</p><p>Prior work had revealed sex-specific differences in the development of disease in the DSS colitis model (<xref ref-type="bibr" rid="bib3">Bábíčková et al., 2015</xref>). When we stratified the data shown in <xref ref-type="fig" rid="fig7">Figure 7B–C</xref> according to mouse sex, we observed no striking differences in the magnitude of <italic>E. coli</italic> H<sub>2</sub> utilization in male and female mice (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>).</p></sec><sec id="s2-6"><title>Hyd-1 and Hyd-2 individually contribute to fitness of <italic>E. coli</italic></title><p>Hyd-1 and Hyd-2 are members of distinct [NiFe]-hydrogenase subgroups, differing in subunit composition and the range of redox potentials at which they function optimally (<xref ref-type="bibr" rid="bib4">Beaton et al., 2018</xref>; <xref ref-type="bibr" rid="bib26">Greening, 2016</xref>; <xref ref-type="bibr" rid="bib53">Lukey, 2010</xref>; <xref ref-type="bibr" rid="bib101">Volbeda et al., 2013</xref>) (reviewed in <xref ref-type="bibr" rid="bib73">Pinske and Sawers, 2016</xref>). Therefore, we decided to investigate which hydrogenase mediated the fitness advantage conferred by H<sub>2</sub> utilization. In the DSS colitis model (<xref ref-type="fig" rid="fig8">Figure 8A</xref>), the EcN wild-type strain outcompeted the Δ<italic>hya</italic> mutant in the colonic and cecal content (3.3-fold and 2.2-fold, respectively) (<xref ref-type="fig" rid="fig8">Figure 8B</xref>). Similarly, the Δ<italic>hyb</italic> mutant was recovered in significantly lower numbers than the EcN wild-type strain from both colonic and cecal content (6.4-fold and 4.7-fold, respectively; <xref ref-type="fig" rid="fig8">Figure 8C</xref>). We thus conclude that both Hyd-1 and Hyd-2 provide a fitness advantage for <italic>E. coli</italic> during colitis.</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Both <italic>hya</italic> and <italic>hyb</italic> enhance fitness of <italic>E</italic>. <italic>coli</italic> Nissle 1917 in the inflamed gut.</title><p>Groups of male (3–4 per group) and female (5 per group) wild-type (WT) C57BL/6 mice received 3% dextran sulfate sodium (DSS) in the drinking water. After 4 days of DSS treatment, the mice were orally inoculated with a 1:1 ratio of the WT <italic>E. coli</italic> Nissle 1917 strain and the indicated isogenic mutants. (<bold>A</bold>) Mouse body weights. Data points represent geometric means ± standard error. (<bold>B</bold>) Abundance of the WT strain (black bars) and the isogenic Hyd-1 mutant (Δ<italic>hya</italic> mutant; blue bars) in the intestinal content. (<bold>C</bold>) Abundance of the WT strain (black bars) and the isogenic Hyd-2 mutant (Δ<italic>hyb</italic> mutant; green bars) in the intestinal content. (<bold>B, C</bold>) The competitive index (CI) is indicated above each set of bars. Each symbol corresponds to one mouse. Bars represent geometric means ± 95% confidence intervals. Statistical significance was determined by paired Student’s <italic>t</italic>-test of the log-transformed data (**p&lt;0.01; ***p&lt;0.001).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58609-fig8-v1.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Molecular hydrogen metabolism is widely utilized across microbial phyla, and hydrogenases are used by bacteria in diverse ecosystems (<xref ref-type="bibr" rid="bib1">Adam and Perner, 2018</xref>; <xref ref-type="bibr" rid="bib26">Greening, 2016</xref>; <xref ref-type="bibr" rid="bib35">Jordaan et al., 2020</xref>; <xref ref-type="bibr" rid="bib71">Piché-Choquette and Constant, 2019</xref>; <xref ref-type="bibr" rid="bib110">Wolf, 2016</xref>). H<sub>2</sub> metabolism supports microbial respiration, fermentation, and carbon fixation (<xref ref-type="bibr" rid="bib99">Vignais and Billoud, 2007</xref>). Recent work by Greening and colleagues provides a detailed classification system of hydrogenases, enabling prediction of biological function (<xref ref-type="bibr" rid="bib26">Greening, 2016</xref>; <xref ref-type="bibr" rid="bib89">Søndergaard et al., 2016</xref>). In our study, we used the HydDB classification to analyze H<sub>2</sub> metabolism in the murine and human gastrointestinal tracts, of which there is still an incomplete understanding (<xref ref-type="bibr" rid="bib5">Benoit et al., 2020</xref>). Our data suggests that H<sub>2</sub> metabolism is perturbed during murine non-infectious colitis and in human IBD patients. We propose that animal models of colitis could be useful tools to probe the physiological role of H<sub>2</sub> metabolism in the gut microbiota. Our work also highlights the value of analyzing large datasets based on knowledge of enzymatic functions. The HydDB database allowed us to identify inflammation-associated changes in microbial H<sub>2</sub> metabolism in the mouse and human gut that were not obvious based on standard bioinformatic analyses of shotgun metagenomic sequencing.</p><p>H<sub>2</sub> is a key metabolite involved in cross-feeding between members of the gut microbiota (reviewed in <xref ref-type="bibr" rid="bib88">Smith, 2019</xref>). H<sub>2</sub> production can be used to dispose of electrons; H<sub>2</sub> consumption allows for the utilization of H<sub>2</sub> as a high-energy electron donor. H<sub>2</sub> metabolism supports gut colonization of methanogens, acetogens, and sulfate-reducing bacteria (<xref ref-type="bibr" rid="bib7">Bernalier, 1996</xref>; <xref ref-type="bibr" rid="bib76">Rey, 2013</xref>; <xref ref-type="bibr" rid="bib79">Ruaud et al., 2020</xref>; <xref ref-type="bibr" rid="bib81">Samuel, 2007</xref>), and these microbes, in turn, prevent the accumulation of a high H<sub>2</sub> partial pressure that can inhibit polysaccharide fermentation (<xref ref-type="bibr" rid="bib80">Samuel and Gordon, 2006</xref>; <xref ref-type="bibr" rid="bib94">Stams, 1994</xref>). The increased abundance of genes encoding uptake hydrogenases in microbial communities in the inflamed gut and the enhanced fitness advantage provided by H<sub>2</sub> oxidation to <italic>E. coli</italic> in murine models of colitis are consistent with an inflammation-disruption of H<sub>2</sub> syntrophic networks. Previous work with <italic>Clostridium difficile</italic> established that <italic>C. difficile</italic> expands due to accumulation of the metabolite succinate via loss of microbial consumption (<xref ref-type="bibr" rid="bib19">Ferreyra, 2014</xref>). The lack of succinate consumption by the microbiota was shown to occur during antibiotic treatment, chemically induced motility disturbance, and impaired IL-22-mediated host glycosylation (<xref ref-type="bibr" rid="bib19">Ferreyra, 2014</xref>; <xref ref-type="bibr" rid="bib65">Nagao-Kitamoto, 2020</xref>). It is conceivable that changes in microbe-microbe H<sub>2</sub> exchange during inflammation might allow <italic>E. coli</italic> to access a H<sub>2</sub> pool.</p><p>Simple electron transport chains typically catalyze two sets of redox reactions that involve proton transfer across the membrane; in one reaction, an electron donor is oxidized, and electrons are transferred to the quinone pool; in the other reaction, electrons from the quinone pool are used to reduce a terminal electron acceptor. Here, we demonstrate that in the inflamed intestine, H<sub>2</sub> utilization via Hyd-1 and Hyd-2 requires fumarate reductase, cytochrome bd-II oxidase, or nitrate reductase activity (<xref ref-type="fig" rid="fig9">Figure 9</xref>). Nitrate is generated as a by-product of reactive nitrogen species metabolism and nitrate respiration contributes to the expansion of Enterobacteriaceae family members during flares (<xref ref-type="bibr" rid="bib31">Hughes, 2017</xref>; <xref ref-type="bibr" rid="bib108">Winter, 2013</xref>). Detoxification of inflammatory reactive oxygen species in the inflamed gut gives <italic>E. coli</italic> access to molecular oxygen and facilitates respiration via AppBCX (<xref ref-type="bibr" rid="bib11">Chanin, 2020</xref>). Curiously, Hyd-1 is oxygen-tolerant (<xref ref-type="bibr" rid="bib54">Lukey, 2011</xref>; <xref ref-type="bibr" rid="bib100">Volbeda et al., 2012</xref>) but induced under anaerobic conditions (<xref ref-type="bibr" rid="bib8">Brøndsted and Atlung, 1994</xref>; <xref ref-type="bibr" rid="bib77">Richard et al., 1999</xref>). The fact that bacterial nitrate respiration and AppBCX-dependent oxygen respiration are consequences of the host’s inflammatory reactive oxygen and nitrogen metabolism may in part explain why H<sub>2</sub> utilization contributes to the bloom of <italic>E. coli</italic> in mouse models of colitis. The concentration of free fumarate is very low in the large intestine, but fumarate can readily be generated from other sources such as aspartate or malate (<xref ref-type="bibr" rid="bib66">Nguyen, 2020</xref>; <xref ref-type="bibr" rid="bib82">Schubert et al., 2021</xref>). Abolishing utilization of a single-electron acceptor did not entirely abrogate H<sub>2</sub> utilization. This outcome is consistent with a scenario in which these three electron acceptors couple to Hyd-1 or Hyd-2 in different, spatially distinct, subpopulations or at different time points as inflammation develops.</p><fig id="fig9" position="float"><label>Figure 9.</label><caption><title>Graphical representation of findings.</title><p>During inflammation, <italic>E. coli</italic> couples oxidation of molecular hydrogen via hydrogenase-1 (Hyd-1) and hydrogenase-2 (Hyd-2) to the reduction of oxygen, nitrate, and fumarate. Inflammatory reactive oxygen species (ROS) and reactive nitrogen species (RNS) leaking into the gut lumen allow for AppBCX (App)-mediated oxygen respiration and nitrate respiration (NR). Frd: fumarate reductase.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-58609-fig9-v1.tif"/></fig><p>While we failed to find evidence that Hyd-1 and Hyd-2 enhance <italic>E. coli</italic> fitness in the absence of inflammation, it is possible that H<sub>2</sub> utilization still occurs in this setting. For example, it is conceivable that our assays were not sensitive enough to detect small fitness defects, that H<sub>2</sub> oxidation occurs in the absence of inflammation but redundant electron-donating enzymes in the electron transport chain mask the phenotype, or that <italic>E. coli’s</italic> access to the H<sub>2</sub> pool is dependent on other microbes. Another caveat of our study is that we were not able perform functional analyses of Hyd-1 in vitro.</p><p>Hydrogenases are also widespread in enteric pathogens (<xref ref-type="bibr" rid="bib5">Benoit et al., 2020</xref>) and H<sub>2</sub> metabolism contributes to gut colonization by <italic>Helicobacter pylori</italic> (<xref ref-type="bibr" rid="bib67">Olson and Maier, 2002</xref>), <italic>Campylobacter jejuni</italic> (<xref ref-type="bibr" rid="bib105">Weerakoon, 2009</xref>), and <italic>Salmonella enterica</italic> serovar Typhimurium (<italic>S</italic>Tm) (<xref ref-type="bibr" rid="bib58">Maier, 2013</xref>). H<sub>2</sub> uptake is important for <italic>S</italic>Tm virulence (<xref ref-type="bibr" rid="bib43">Lamichhane-Khadka, 2015</xref>; <xref ref-type="bibr" rid="bib57">Maier, 2004</xref>), and it facilitates <italic>S</italic>Tm gut colonization (<xref ref-type="bibr" rid="bib59">Maier et al., 2014</xref>; <xref ref-type="bibr" rid="bib58">Maier, 2013</xref>) and fecal shedding (<xref ref-type="bibr" rid="bib42">Lam and Monack, 2014</xref>). The role of hydrogenases with regards to <italic>S</italic>Tm systemic colonization has resulted in different outcomes, depending on the bacterial strain, route of inoculation, mouse background, and gut microbiota status (<xref ref-type="bibr" rid="bib15">Craig, 2013</xref>; <xref ref-type="bibr" rid="bib59">Maier et al., 2014</xref>). In our study, we observed that H<sub>2</sub> uptake contributes to gut colonization in a mouse and human commensal <italic>E. coli</italic> strain, and both Hyd-1 and Hyd-2 play a role in facilitating <italic>E. coli</italic> gut colonization during non-infectious colitis.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Bacterial strains, plasmids, and primers</title><p>All bacterial strains and plasmids are listed in Appendix 1—key resources table. Primers are listed in Appendix 1—key resources table and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. <italic>E. coli</italic> strains were routinely grown in LB broth (10 g/l tryptone, 5 g/l yeast extract, 10 g/l sodium chloride) or on LB plates (LB broth, 15 g/l agar) under aerobic conditions at 30°C or 37°C. When necessary, the antibiotics chloramphenicol (Cm), kanamycin (Kan), and carbenicillin (Carb) were added at concentrations of 15 mg/l, 100 mg/l, and 100 mg/l, respectively.</p><p>Suicide plasmids were constructed with use of a Gibson Assembly Cloning Kit (New England Biolabs, Ipswich, MA). To generate pEL1 and pEL2, regions upstream and downstream of <italic>hyaABC</italic> and <italic>hybABC</italic>, respectively, were PCR amplified from <italic>E. coli</italic> Nissle 1917 (EcN) with Q5 Hot Start High-Fidelity DNA Polymerase (New England Biolabs). The upstream and downstream regions of the genes of interest were inserted into SphI-digested pRDH10 by Gibson cloning. For pEL29 and pEL30, <italic>E. coli</italic> MP1 was used as the PCR template and the flanking regions of the genes of interest were inserted into SphI-digested pGP706. For pEL35, flanking regions of <italic>frdABCD</italic> were PCR amplified from EcN and inserted into SphI-digested pGP706. Prior to mutagenesis, plasmid inserts were sequenced to check for point mutations.</p><p>Suicide plasmids were propagated in DH5α λ<italic>pir</italic>. S17-1 λ<italic>pir</italic> was used as the donor strain to introduce suicide plasmids into EcN (pSW172) or MP1 (pSW172) strains via conjugation. Conjugation experiments were performed at 30°C to enable stable replication of the temperature-sensitive plasmid pSW172. Exconjugants in which the suicide plasmid had integrated into the chromosome were selected at 30°C with LB plates containing Cm and Carb (for the cloning with vector pRDH10) or Kan and Carb (for the cloning with vector pGP706). Mutants in which second crossover events had occurred were selected by plating on sucrose plates (5% sucrose, 15 g/l agar, 8 g/l nutrient broth base). Clean, unmarked deletions were confirmed by PCR. pSW172 was cured by growing the bacteria at 37°C. The strains EL5, EL11, EL15, EL252, EL276, EL284, EL347, EL350, and EL363 were generated using this cloning strategy.</p><p>To construct pEL32 for complementation of <italic>hyb</italic>, the promoter region of <italic>hyb</italic> and the coding sequence of <italic>hybABC</italic> were PCR amplified from EcN with Q5 Hot Start High-Fidelity DNA Polymerase (New England Biolabs, Ipswich, MA). The sequences of interest were inserted into EcoRI-digested pWSK129 via Gibson Assembly (New England Biolabs). pEL32 was electroporated into the appropriate EcN strain to test complementation of the <italic>hyb</italic> deletion.</p></sec><sec id="s4-2"><title>Mouse experiments</title><p>Specific pathogen-free (SPF) mice were used for the experiments. Male and female 6–18-week-old wild-type (WT) C57BL/6, <italic>Il10</italic><sup>-/-</sup> C57BL/6, and <italic>Il10</italic><sup>-/-</sup> BALB/c mice were used. Five mice at most were housed per cage. Mice were randomly assigned to groups prior to experimentation. Mice included animals obtained from the Jackson Laboratory (Bar Harbor, ME) and animals originally from the Jackson Laboratory (Bar Harbor) and bred under SPF conditions in a barrier facility at UT Southwestern. Mice were on a 12 hr light/dark cycle and had access to food and water ad libitum. All mouse experiments were reviewed and approved by the Institute of Animal Care and Use Committee at UT Southwestern.</p></sec><sec id="s4-3"><title><italic>E. coli</italic> colonization experiments in the DSS-induced colitis model</title><p>Male and female WT C57BL/6 mice were used. Colitis was induced by administering a filter-sterilized solution of 3% (wt/vol) DSS (Alfa Aesar, Haverhill, MA) in water to drink. Mouse body weights and health were monitored daily. For competitive colonization experiments, mice were inoculated by oral gavage with 5 × 10<sup>8</sup> CFU of each indicated <italic>E. coli</italic> strain in LB broth at the indicated time points. For the single colonization experiment (<xref ref-type="fig" rid="fig3">Figure 3</xref>), mice were orally inoculated with 1 × 10<sup>9</sup> CFU of either the wild-type strain or the mutant. After 8 days of DSS treatment, DSS-supplemented water was switched to regular drinking water for 1 day. Then, mice were euthanized, and colonic and cecal contents were harvested in sterile phosphate-buffered saline (PBS; pH = 7.4) and placed on ice. To determine the abundance of the respective strains, 10-fold serial dilutions of intestinal content were plated on LB agar plates containing Kan or Carb. Wild-type and mutant strains were marked with the low-copy plasmids pWSK129 (Kan<sup>R</sup>) or pWSK29 (Carb<sup>R</sup>) to facilitate recovery from competitive colonization experiments. Colon length and colonic and cecal tissue samples were collected from the indicated experiments. Colonic and cecal tissue for quantification of mRNA was flash frozen and stored at –80°C. Colonic and cecal tissue for histopathology analysis was collected in 10% buffered formalin phosphate (Thermo Fisher) for fixation.</p></sec><sec id="s4-4"><title><italic>E. coli</italic> colonization experiment in healthy mice</title><p>Male and female WT C57BL/6 mice were used. Mice were inoculated by oral gavage with 5 × 10<sup>8</sup> CFU each of the wild-type MP1 strain and the Δ<italic>hya</italic> Δ<italic>hyb</italic> mutant in LB broth. Mice were euthanized 3 days after colonization, and colonic and cecal contents were collected as described previously.</p></sec><sec id="s4-5"><title><italic>E. coli</italic> colonization experiments in piroxicam-accelerated <italic>Il10</italic><sup>-/-</sup> colitis model</title><p>Male and female 11–18-week-old <italic>Il10</italic><sup>-/-</sup> C57BL/6 and <italic>Il10</italic><sup>-/-</sup> BALB/c mice were used. <italic>Il10</italic><sup>-/-</sup> C57BL/6 received piroxicam-fortified diet (100 ppm; Teklad custom research diets, Envigo, Indianapolis, IN) instead of the regular mouse chow (Teklad global 16% protein diet, irradiated, Envigo 2916) for 9 days total. <italic>Il10</italic><sup>-/-</sup> BALB/c mice were fed piroxicam-fortified diet (50 ppm for EcN-colonized mice and 100 ppm for MP1-colonized mice) for 16 days total. The piroxicam diet was changed daily. Two days after the start of piroxicam treatment, mice were orally inoculated with 5 × 10<sup>8</sup> CFU of each indicated <italic>E. coli</italic> strain. At the end of the experiment, mice were euthanized and samples collected as described previously. Cages of mice in which the mice did not lose body weight or colonize with the indicated <italic>E. coli</italic> strains were excluded from analysis.</p></sec><sec id="s4-6"><title>Histopathology analysis</title><p>Colonic and cecal tissue was formalin-fixed (10% buffered formalin phosphate; Thermo Fisher), embedded in paraffin, and stained with hematoxylin and eosin. The samples were blinded and scored by a veterinary pathologist according to criteria described in <xref ref-type="bibr" rid="bib108">Winter, 2013</xref>.</p></sec><sec id="s4-7"><title>Intestinal mRNA analysis</title><p>The relative transcription levels of <italic>Cxcl1</italic>, <italic>Nos2</italic>, and <italic>Tnfa</italic> genes were determined by RT-qPCR and normalized to <italic>Gapdh</italic> mRNA levels. RNA was extracted via the TRI reagent method (Molecular Research Center), mRNA was purified with NEBNext Poly(A) mRNA Magnetic Isolation Module (New England Biolabs), and cDNA was then synthesized with TaqMan reverse transcription reagents (Life Technologies). qPCR was performed in a QuantStudio 6 Flex Instrument (Life Technologies) with SYBR Green (Applied Biosystems) using the primers listed in Appendix 1—key resources table. Results were analyzed using the comparative Ct method.</p></sec><sec id="s4-8"><title>Growth curves</title><p>Growth curves were performed in filter sterilized (0.22 μm) M9 minimal medium (6.8 g/l sodium phosphate dibasic anhydrous, 3 g/l potassium phosphate monobasic anhydrous, 0.5 g/l sodium chloride, 1 g/l ammonium chloride, 1 mM magnesium sulfate, 0.1 mM calcium chloride; pH = 7.0) supplemented with 20 mM glucose as the carbon source. The indicated <italic>E. coli</italic> strains were grown aerobically in LB broth at 37°C overnight. Then, strains were diluted in M9 medium supplemented with glucose at a final concentration of 1 × 10<sup>8</sup> CFU/ml. Cultures were incubated aerobically at 37°C with shaking at 250 rpm. The optical density at 600 nm (OD<sub>600</sub>) was measured every 30 min. The experiment was performed in triplicate for each strain.</p></sec><sec id="s4-9"><title>Growth of <italic>E. coli</italic> strains in mucin broth</title><p>Porcine stomach mucin type II (100 mg) (Sigma) was sterilized by suspending mucin in 1 ml of 70% ethanol and incubating at 65°C for 2 hr. The suspension was then cooled overnight at room temperature (25°C) and the ethanol was aspirated. Mucin pellets were further dried using a vacufuge plus centrifuge (Eppendorf).</p><p>Mucin broth was generated by suspending 0.5% [w/v] dried sterile mucin in No-Carbon E medium (NCE) (3.94 g/l monopotassium phosphate, 5.9 g/l dipotassium phosphate, 4.68 g/l ammonium sodium hydrogen phosphate tetrahydrate, 2.46 g/l magnesium sulfate heptahydrate), supplemented with 1 mM magnesium sulfate. Where indicated, mucin broth was either supplemented with water, nitrate (0.4 mM or 40 mM, as indicated), or fumarate (25 mM). Overnight cultures of the indicated <italic>E. coli</italic> strains were used to inoculate the mucin broth at a concentration of 1 × 10<sup>3</sup> CFU/ml of each strain. Cultures were incubated anaerobically (90% N<sub>2</sub>, 5% CO<sub>2</sub>, 5% H<sub>2</sub>; Sheldon Manufacturing) for 18 hr at 37°C in glass flasks (high surface area-to-volume ratio). Then, the abundance of the respective strains was determined by plating 10-fold serial dilutions on LB agar plates containing Kan or Carb. Wild-type and mutant strains were marked with the low-copy plasmids pWSK129 (Kan<sup>R</sup>) or pWSK29 (Amp<sup>R</sup>/Carb<sup>R</sup>) to facilitate recovery from competitive growth experiments.</p></sec><sec id="s4-10"><title>Metagenomic analysis of murine samples</title><p>A published metagenomic dataset of DSS-induced murine colitis mode, available at the European Nucleotide Archive, accession number PRJEB15095 (<xref ref-type="bibr" rid="bib31">Hughes, 2017</xref>), was reanalyzed to evaluate hydrogenase abundance in the cecal microbial community. Raw reads were processed using BBMap software suite (DOE Joint Genome Institute, Walnut Creek, CA) to remove adapters and low-quality reads. Reads were then decontaminated against mouse genome using Bowtie2 (<xref ref-type="bibr" rid="bib44">Langmead and Salzberg, 2012</xref>). Global, untargeted mapping was performed using diamond blast (<xref ref-type="bibr" rid="bib9">Buchfink, 2015</xref>) against the NCBI non-redundant database. Mapped reads were parsed, annotated, and visualized using the MEGAN5 metagenomic software suite (<xref ref-type="bibr" rid="bib32">Huson, 2007</xref>; <xref ref-type="bibr" rid="bib33">Huson et al., 2016</xref>).</p><p>To evaluate the abundance of different hydrogenase categories in this metagenomic dataset, diamond blast (reporting e-value cutoff: 0.001; <xref ref-type="bibr" rid="bib9">Buchfink, 2015</xref>) was used to blast clean, filtered reads against the HydDB hydrogenase database (<xref ref-type="bibr" rid="bib89">Søndergaard et al., 2016</xref>). Raw hits of individual samples were summarized using the FMAP_table.pl function in FMAP (<xref ref-type="bibr" rid="bib37">Kim, 2016</xref>) with the -c parameter. The differential abundance of each hydrogenase category was then calculated using DESeq2 (<xref ref-type="bibr" rid="bib52">Love, 2014</xref>), normalizing to the total number of reads aligned to all hydrogenases queried.</p><p>To test the accuracy of annotations in the HydDB database, we aligned simulated metagenomic datasets of hydrogenase-containing and hydrogenase-free genomes to the HydDB database and compared the relative abundance of mapped reads between datasets. Genomes of five representative members of the gut microbiome were used as a starting point. The hydrogenase-free genomes were generated by removing sequences of all known hydrogenases from the corresponding wild-type genomes. 100 bp, paired-end illumine reads were simulated using the genomes of representative members of various phyla in the gut microbiome (<italic>Akkermansia muciniphila</italic> ATCC BAA-835, <italic>Bacteroides fragilis</italic> NCTC 9343, <italic>Faecalibacterium prausnitzii</italic> APC918/95b, <italic>Bacteroides thetaiotaomicron</italic> VPI-5482, and <italic>E. coli</italic> Nissle 1917). The simulation was performed using ART (<xref ref-type="bibr" rid="bib30">Huang, 2012</xref>) to achieve 2000-fold coverage (parameter: -f 2000) of the respective genomes. Sequences of known hydrogenases were removed from the stated genomes and reads of the in silico knock-out genomes were simulated as stated above. The simulated reads from the wild-type and corresponding hydrogenases knock-out genomes were aligned to the HydDB database using Diamond blast with default parameters. Mapped reads were quantified using FMAP as stated above. In the simulated datasets, reads mapped to the known hydrogenases were significantly more abundant in the hydrogenase-containing dataset than in the hydrogenase-free dataset. However, 21 HydDB entries (out of 3248) had higher than twofold enrichment of reads that mapped to the hydrogenase-free dataset than the hydrogenase-containing dataset. This suggested that those 21 HydDB entries may be incorrectly annotated or may share too high of homology with non-hydrogenase encoding DNA sequences of the representative gut microbiome genomes to be reliably annotated as hydrogenases in our study. Therefore, the HydDB entries that had twofold or greater relative abundance of reads in the hydrogenase knock-out dataset than in the wild-type dataset were removed from the classification of hydrogenases to yield a curated list of mapped hydrogenases (<xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>).</p></sec><sec id="s4-11"><title>Metagenomic analysis of human samples</title><p>A published metagenomic sequencing dataset of stool samples from IBD patients and non-IBD controls (available via SRA with BioProject number PRJNA400072, <xref ref-type="bibr" rid="bib22">Franzosa, 2019</xref>) was analyzed to evaluate hydrogenase abundance. Of note, of the 220 samples in this dataset, 218 samples were analyzed as the data of two samples were corrupted. Reads were trimmed and filtered against the human genome, and then aligned to the hydrogenase database (<xref ref-type="bibr" rid="bib89">Søndergaard et al., 2016</xref>) using diamond blast (reporting e-value cutoff: 0.001, <xref ref-type="bibr" rid="bib9">Buchfink, 2015</xref>). Raw hits of individual samples were summarized using the FMAP_table.pl function in FMAP (<xref ref-type="bibr" rid="bib37">Kim, 2016</xref>) with the -c parameter. The differential abundance of each hydrogenase category was then calculated using DESeq2 (<xref ref-type="bibr" rid="bib52">Love, 2014</xref>), normalizing to the total number of reads aligned to all hydrogenases queried. The HydDB entries previously excluded in the murine metagenomic analysis, based on our in silico HydDB validation, were also excluded from the human sample analysis (<xref ref-type="supplementary-material" rid="fig1sdata2">Figure 1—source data 2</xref> and <xref ref-type="supplementary-material" rid="fig1sdata3">3</xref>).</p></sec><sec id="s4-12"><title>Statistical analysis</title><p>Data were analyzed and graphs created using Microsoft Excel, PowerPoint, GraphPad Prism, and BioRender. p values &lt;0.05 were considered statistically significant.</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>The corresponding author (SEW) is listed as an inventor on patent application WO2014200929A1, which describes a treatment to prevent the inflammation-associated expansion of Enterobacteriaceae.</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Investigation, writing-original-draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, funding-acquisition, writing-original-draft, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All mouse experiments were reviewed and approved by the Institute of Animal Care and Use Committee at UT Southwestern (Protocol Numbers: 101681 and 102091). UT Southwestern uses the &quot;Guide for the Care and Use of Laboratory Animals&quot; when establishing animal research standards.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Primers for mutagenesis generated for this study.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-58609-supp1-v1.docx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-58609-transrepform1-v1.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>A published metagenomic dataset of DSS-induced murine colitis model (available at the European Nucleotide Archive, accession number PRJEB15095, Hughes et al., 2017) was reanalyzed to evaluate hydrogenase abundance in the cecal microbial community. A published metagenomic sequencing dataset of stool samples from IBD patients and non-IBD controls (available via SRA with BioProject number PRJNA400072, Franzosa et al., 2019) was analyzed to evaluate hydrogenase abundance. Source files have been provided for Figure1.</p><p>The following previously published datasets were used:</p><p><element-citation id="dataset1" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>ER</given-names></name><name><surname>Winter</surname><given-names>MG</given-names></name><name><surname>Duerkop</surname><given-names>BA</given-names></name><name><surname>Spiga</surname><given-names>L</given-names></name><name><surname>Furtado de Carvalho</surname><given-names>T</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Gillis</surname><given-names>CC</given-names></name><name><surname>Büttner</surname><given-names>L</given-names></name><name><surname>Smoot</surname><given-names>MP</given-names></name><name><surname>Behrendt</surname><given-names>CL</given-names></name><name><surname>Cherry</surname><given-names>S</given-names></name><name><surname>Santos</surname><given-names>RL</given-names></name><name><surname>Hooper</surname><given-names>LV</given-names></name><name><surname>Winter</surname><given-names>SE</given-names></name></person-group><year iso-8601-date="2016">2016</year><data-title>Metagenomic sequencing of cecal microbiota from DSS colitis mouse model</data-title><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/ena/data/view/PRJEB15095">https://www.ebi.ac.uk/ena/data/view/PRJEB15095</ext-link><source>European Nucleotide Archive</source><pub-id pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/ena/data/view/PRJEB15095">PRJEB15095</pub-id></element-citation></p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Franzosa</surname><given-names>EA</given-names></name><name><surname>Sirota-Madi</surname><given-names>A</given-names></name><name><surname>Avila-Pacheco</surname><given-names>J</given-names></name><name><surname>Fornelos</surname><given-names>N</given-names></name><name><surname>Haiser</surname><given-names>HJ</given-names></name><name><surname>Reinker</surname><given-names>S</given-names></name><name><surname>Vatanen</surname><given-names>T</given-names></name><name><surname>Hall</surname><given-names>AB</given-names></name><name><surname>Mallick</surname><given-names>H</given-names></name><name><surname>McIver</surname><given-names>LJ</given-names></name><name><surname>Sauk</surname><given-names>JS</given-names></name><name><surname>Wilson</surname><given-names>RG</given-names></name><name><surname>Stevens</surname><given-names>BW</given-names></name><name><surname>Scott</surname><given-names>JM</given-names></name><name><surname>Pierce</surname><given-names>K</given-names></name><name><surname>Deik</surname><given-names>AA</given-names></name><name><surname>Bullock</surname><given-names>K</given-names></name><name><surname>Imhann</surname><given-names>F</given-names></name><name><surname>Porter</surname><given-names>JA</given-names></name><name><surname>Zhernakova</surname><given-names>A</given-names></name><name><surname>Fu</surname><given-names>J</given-names></name><name><surname>Weersma</surname><given-names>RK</given-names></name><name><surname>Wijmenga</surname><given-names>C</given-names></name><name><surname>Clish</surname><given-names>CB</given-names></name><name><surname>Vlamakis</surname><given-names>H</given-names></name><name><surname>Huttenhower</surname><given-names>C</given-names></name><name><surname>Xavier</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><data-title>Gut microbiome structure and metabolic activity in inflammatory bowel disease</data-title><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA400072">https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA400072</ext-link><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA400072">PRJNA400072</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Dr. Mark Goulian (University of Pennsylvania) for providing <italic>E. coli</italic> MP1. Work in SEW’s lab was funded by the NIH (AI118807, AI128151), The Welch Foundation (I-1969-20180324), the Burroughs Wellcome Fund (1017880), and a Research Scholar Grant (RSG-17-048-01-MPC) from the American Cancer Society. WZ was supported by a Research Fellows Award from the Crohn’s and Colitis Foundation of America (454921). ERH and RBC were supported by a NIH T32 training grant (AI007520). CCG was supported by an NSF GRFP (1000194723). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the funding agencies. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adam</surname><given-names>N</given-names></name><name><surname>Perner</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Microbially mediated hydrogen cycling in deep-sea hydrothermal vents</article-title><source>Frontiers in Microbiology</source><volume>9</volume><elocation-id>2873</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2018.02873</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anne</surname><given-names>V</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Crystal structure of the nickel-iron hydrogenase from Desulfovibrio gigas</article-title><source>Nature</source><volume>373</volume><fpage>580</fpage><lpage>587</lpage><pub-id pub-id-type="doi">10.1038/373580a0</pub-id><pub-id pub-id-type="pmid">7854413</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bábíčková</surname><given-names>J</given-names></name><name><surname>Tóthová</surname><given-names>Ľ</given-names></name><name><surname>Lengyelová</surname><given-names>E</given-names></name><name><surname>Bartoňová</surname><given-names>A</given-names></name><name><surname>Hodosy</surname><given-names>J</given-names></name><name><surname>Gardlík</surname><given-names>R</given-names></name><name><surname>Celec</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Sex differences in experimentally induced colitis in mice: A role for estrogens</article-title><source>Inflammation</source><volume>38</volume><fpage>1996</fpage><lpage>2006</lpage><pub-id pub-id-type="doi">10.1007/s10753-015-0180-7</pub-id><pub-id pub-id-type="pmid">25962374</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beaton</surname><given-names>SE</given-names></name><name><surname>Evans</surname><given-names>RM</given-names></name><name><surname>Finney</surname><given-names>AJ</given-names></name><name><surname>Lamont</surname><given-names>CM</given-names></name><name><surname>Armstrong</surname><given-names>FA</given-names></name><name><surname>Sargent</surname><given-names>F</given-names></name><name><surname>Carr</surname><given-names>SB</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The structure of hydrogenase-2 from <italic>Escherichia coli</italic>: Implications for h2-driven proton pumping</article-title><source>The Biochemical Journal</source><volume>475</volume><fpage>1353</fpage><lpage>1370</lpage><pub-id pub-id-type="doi">10.1042/BCJ20180053</pub-id><pub-id pub-id-type="pmid">29555844</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benoit</surname><given-names>SL</given-names></name><name><surname>Maier</surname><given-names>RJ</given-names></name><name><surname>Sawers</surname><given-names>RG</given-names></name><name><surname>Greening</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Molecular hydrogen metabolism: a widespread trait of pathogenic bacteria and protists</article-title><source>Microbiology and Molecular Biology Reviews</source><volume>84</volume><elocation-id>e00092-19</elocation-id><pub-id pub-id-type="doi">10.1128/MMBR.00092-19</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berg</surname><given-names>DJ</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Weinstock</surname><given-names>JV</given-names></name><name><surname>Ismail</surname><given-names>HF</given-names></name><name><surname>Earle</surname><given-names>KA</given-names></name><name><surname>Alila</surname><given-names>H</given-names></name><name><surname>Pamukcu</surname><given-names>R</given-names></name><name><surname>Moore</surname><given-names>S</given-names></name><name><surname>Lynch</surname><given-names>RG</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Rapid development of colitis in nsaid-treated il-10-deficient mice</article-title><source>Gastroenterology</source><volume>123</volume><fpage>1527</fpage><lpage>1542</lpage><pub-id pub-id-type="doi">10.1053/gast.2002.1231527</pub-id><pub-id pub-id-type="pmid">12404228</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernalier</surname><given-names>W</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Ruminococcus hydrogenotrophicus sp. nov., a new H2/CO2-utilizing acetogenic bacterium isolated from human feces</article-title><source>Archives of Microbiology</source><volume>166</volume><fpage>176</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1007/s002030050373</pub-id><pub-id pub-id-type="pmid">8703194</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brøndsted</surname><given-names>L</given-names></name><name><surname>Atlung</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Anaerobic regulation of the hydrogenase 1 (HYA) operon of <italic>Escherichia coli</italic></article-title><source>Journal of Bacteriology</source><volume>176</volume><fpage>5423</fpage><lpage>5428</lpage><pub-id pub-id-type="doi">10.1128/JB.176.17.5423-5428.1994</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buchfink</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Fast and sensitive protein alignment using DIAMOND</article-title><source>Nature Methods</source><volume>12</volume><fpage>59</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3176</pub-id><pub-id pub-id-type="pmid">25402007</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cevallos</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Increased Epithelial Oxygenation Links Colitis to an Expansion of Tumorigenic Bacteria</article-title><source>MBio</source><volume>10</volume><elocation-id>e02244-19</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.02244-19</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chanin</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Epithelial-Derived Reactive Oxygen Species Enable AppBCX-Mediated Aerobic Respiration of <italic>Escherichia coli</italic> during Intestinal Inflammation</article-title><source>Cell Host &amp; Microbe</source><volume>28</volume><fpage>780</fpage><lpage>788</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2020.09.005</pub-id><pub-id pub-id-type="pmid">33053375</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chassaing</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Dextran sulfate sodium (DSS)-induced colitis in mice</article-title><source>Current Protocols in Immunology</source><volume>104</volume><fpage>15</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1002/0471142735.im1525s104</pub-id><pub-id pub-id-type="pmid">24510619</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cockburn</surname><given-names>DW</given-names></name><name><surname>Koropatkin</surname><given-names>NM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Polysaccharide degradation by the intestinal microbiota and its influence on human health and disease</article-title><source>Journal of Molecular Biology</source><volume>428</volume><fpage>3230</fpage><lpage>3252</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2016.06.021</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Clinicopathologic study of dextran sulfate sodium experimental murine colitis</article-title><source>Laboratory Investigation; a Journal of Technical Methods and Pathology</source><volume>69</volume><fpage>238</fpage><lpage>249</lpage></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Craig</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Twin-arginine translocation system (tat) mutants of Salmonella are attenuated due to envelope defects, not respiratory defects</article-title><source>Molecular Microbiology</source><volume>89</volume><fpage>887</fpage><lpage>902</lpage><pub-id pub-id-type="doi">10.1111/mmi.12318</pub-id><pub-id pub-id-type="pmid">23822642</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Thermogenic hydrocarbon biodegradation by diverse depth-stratified microbial populations at a Scotian Basin cold seep</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>5825</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-19648-2</pub-id><pub-id pub-id-type="pmid">33203858</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eckburg</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Diversity of the human intestinal microbial flora</article-title><source>Science</source><volume>308</volume><fpage>1635</fpage><lpage>1638</lpage><pub-id pub-id-type="doi">10.1126/science.1110591</pub-id><pub-id pub-id-type="pmid">15831718</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faber</surname><given-names>F</given-names></name><name><surname>Thiennimitr</surname><given-names>P</given-names></name><name><surname>Spiga</surname><given-names>L</given-names></name><name><surname>Byndloss</surname><given-names>MX</given-names></name><name><surname>Litvak</surname><given-names>Y</given-names></name><name><surname>Lawhon</surname><given-names>S</given-names></name><name><surname>Andrews-Polymenis</surname><given-names>HL</given-names></name><name><surname>Winter</surname><given-names>SE</given-names></name><name><surname>Bäumler</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Respiration of microbiota-derived 1,2-propanediol drives salmonella expansion during colitis</article-title><source>PLOS Pathogens</source><volume>13</volume><elocation-id>e1006129</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006129</pub-id><pub-id pub-id-type="pmid">28056091</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreyra</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Gut microbiota-produced succinate promotes C. difficile infection after antibiotic treatment or motility disturbance</article-title><source>Cell Host &amp; Microbe</source><volume>16</volume><fpage>770</fpage><lpage>777</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2014.11.003</pub-id><pub-id pub-id-type="pmid">25498344</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fornelos</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Growth effects of N-acylethanolamines on gut bacteria reflect altered bacterial abundances in inflammatory bowel disease</article-title><source>Nature Microbiology</source><volume>5</volume><fpage>486</fpage><lpage>497</lpage><pub-id pub-id-type="doi">10.1038/s41564-019-0655-7</pub-id><pub-id pub-id-type="pmid">31959971</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases</article-title><source>PNAS</source><volume>104</volume><fpage>13780</fpage><lpage>13785</lpage><pub-id pub-id-type="doi">10.1073/pnas.0706625104</pub-id><pub-id pub-id-type="pmid">17699621</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franzosa</surname><given-names>S-M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Gut microbiome structure and metabolic activity in inflammatory bowel disease</article-title><source>Nature Microbiology</source><volume>4</volume><fpage>293</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1038/s41564-018-0306-4</pub-id><pub-id pub-id-type="pmid">30531976</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrett</surname><given-names>Lord</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system</article-title><source>Cell</source><volume>131</volume><fpage>33</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.08.017</pub-id><pub-id pub-id-type="pmid">17923086</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrett</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis</article-title><source>Cell Host &amp; Microbe</source><volume>8</volume><fpage>292</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2010.08.004</pub-id><pub-id pub-id-type="pmid">20833380</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Godinez</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>T cells help to amplify inflammatory responses induced by <italic>Salmonella enterica</italic> serotype Typhimurium in the intestinal mucosa</article-title><source>Infection and Immunity</source><volume>76</volume><fpage>2008</fpage><lpage>2017</lpage><pub-id pub-id-type="doi">10.1128/IAI.01691-07</pub-id><pub-id pub-id-type="pmid">18347048</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greening</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Genomic and metagenomic surveys of hydrogenase distribution indicate H2 is a widely utilised energy source for microbial growth and survival</article-title><source>The ISME Journal</source><volume>10</volume><fpage>761</fpage><lpage>777</lpage><pub-id pub-id-type="doi">10.1038/ismej.2015.153</pub-id><pub-id pub-id-type="pmid">26405831</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grozdanov</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Analysis of the genome structure of the nonpathogenic probiotic <italic>Escherichia coli</italic> strain Nissle 1917</article-title><source>Journal of Bacteriology</source><volume>186</volume><fpage>5432</fpage><lpage>5441</lpage><pub-id pub-id-type="doi">10.1128/JB.186.16.5432-5441.2004</pub-id><pub-id pub-id-type="pmid">15292145</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haberman</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature</article-title><source>The Journal of Clinical Investigation</source><volume>124</volume><fpage>3617</fpage><lpage>3633</lpage><pub-id pub-id-type="doi">10.1172/JCI75436</pub-id><pub-id pub-id-type="pmid">25003194</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartman</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Human gut microbiome adopts an alternative state following small bowel transplantation</article-title><source>PNAS</source><volume>106</volume><fpage>17187</fpage><lpage>17192</lpage><pub-id pub-id-type="doi">10.1073/pnas.0904847106</pub-id><pub-id pub-id-type="pmid">19805153</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>ART: a next-generation sequencing read simulator</article-title><source>Bioinformatics</source><volume>28</volume><fpage>593</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btr708</pub-id><pub-id pub-id-type="pmid">22199392</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Microbial Respiration and Formate Oxidation as Metabolic Signatures of Inflammation-Associated Dysbiosis</article-title><source>Cell Host &amp; Microbe</source><volume>21</volume><fpage>208</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2017.01.005</pub-id><pub-id pub-id-type="pmid">28182951</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huson</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>MEGAN analysis of metagenomic data</article-title><source>Genome Research</source><volume>17</volume><fpage>377</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1101/gr.5969107</pub-id><pub-id pub-id-type="pmid">17255551</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huson</surname><given-names>DH</given-names></name><name><surname>Beier</surname><given-names>S</given-names></name><name><surname>Flade</surname><given-names>I</given-names></name><name><surname>Górska</surname><given-names>A</given-names></name><name><surname>El-Hadidi</surname><given-names>M</given-names></name><name><surname>Mitra</surname><given-names>S</given-names></name><name><surname>Ruscheweyh</surname><given-names>H-J</given-names></name><name><surname>Tappu</surname><given-names>R</given-names></name><name><surname>Huson</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>MEGAN Community Edition - Interactive Exploration and Analysis of Large-Scale Microbiome Sequencing Data</article-title><source>PLOS Computational Biology</source><volume>12</volume><elocation-id>e1004957</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1004957</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jalili-Firoozinezhad</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip</article-title><source>Nature Biomedical Engineering</source><volume>3</volume><fpage>520</fpage><lpage>531</lpage><pub-id pub-id-type="doi">10.1038/s41551-019-0397-0</pub-id><pub-id pub-id-type="pmid">31086325</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jordaan</surname><given-names>K</given-names></name><name><surname>Lappan</surname><given-names>R</given-names></name><name><surname>Dong</surname><given-names>X</given-names></name><name><surname>Aitkenhead</surname><given-names>IJ</given-names></name><name><surname>Bay</surname><given-names>SK</given-names></name><name><surname>Chiri</surname><given-names>E</given-names></name><name><surname>Wieler</surname><given-names>N</given-names></name><name><surname>Meredith</surname><given-names>LK</given-names></name><name><surname>Cowan</surname><given-names>DA</given-names></name><name><surname>Chown</surname><given-names>SL</given-names></name><name><surname>Greening</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Hydrogen-Oxidizing bacteria are abundant in desert soils and strongly stimulated by hydration</article-title><source>mSystems</source><volume>5</volume><elocation-id>5</elocation-id><pub-id pub-id-type="doi">10.1128/mSystems.01131-20</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaoutari</surname><given-names>AE</given-names></name><name><surname>Armougom</surname><given-names>F</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name><name><surname>Raoult</surname><given-names>D</given-names></name><name><surname>Henrissat</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The abundance and variety of carbohydrate-active enzymes in the human gut microbiota</article-title><source>Nature Reviews Microbiology</source><volume>11</volume><fpage>497</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1038/nrmicro3050</pub-id><pub-id pub-id-type="doi">10.1038/nrmicro3050</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>FMAP: Functional Mapping and Analysis Pipeline for metagenomics and metatranscriptomics studies</article-title><source>BMC Bioinformatics</source><volume>17</volume><elocation-id>420</elocation-id><pub-id pub-id-type="doi">10.1186/s12859-016-1278-0</pub-id><pub-id pub-id-type="pmid">27724866</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kingsley</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Ferrioxamine-mediated Iron(III) utilization by <italic>Salmonella enterica</italic></article-title><source>Applied and Environmental Microbiology</source><volume>65</volume><fpage>1610</fpage><lpage>1618</lpage><pub-id pub-id-type="doi">10.1128/AEM.65.4.1610-1618.1999</pub-id><pub-id pub-id-type="pmid">10103258</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koropatkin</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>How glycan metabolism shapes the human gut microbiota</article-title><source>Nature Reviews. Microbiology</source><volume>10</volume><fpage>323</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2746</pub-id><pub-id pub-id-type="pmid">22491358</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotlowski</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>High prevalence of <italic>Escherichia coli</italic> belonging to the B2+D phylogenetic group in inflammatory bowel disease</article-title><source>Gut</source><volume>56</volume><fpage>669</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1136/gut.2006.099796</pub-id><pub-id pub-id-type="pmid">17028128</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuhn</surname><given-names>L</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Interleukin-10-deficient mice develop chronic enterocolitis</article-title><source>Cell</source><volume>75</volume><fpage>263</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(93)80068-p</pub-id><pub-id pub-id-type="pmid">8402911</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>LH</given-names></name><name><surname>Monack</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Intraspecies competition for niches in the distal gut dictate transmission during persistent salmonella infection</article-title><source>PLOS Pathogens</source><volume>10</volume><elocation-id>e1004527</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1004527</pub-id><pub-id pub-id-type="pmid">25474319</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamichhane-Khadka</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Host hydrogen rather than that produced by the pathogen is important for <italic>Salmonella enterica</italic> serovar Typhimurium virulence</article-title><source>Infection and Immunity</source><volume>83</volume><fpage>311</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1128/IAI.02611-14</pub-id><pub-id pub-id-type="pmid">25368112</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langmead</surname><given-names>B</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fast gapped-read alignment with Bowtie 2</article-title><source>Nature Methods</source><volume>9</volume><fpage>357</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1923</pub-id><pub-id pub-id-type="pmid">22388286</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lasaro</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title><italic>Escherichia coli</italic> isolate for studying colonization of the mouse intestine and its application to two-component signaling knockouts</article-title><source>Journal of Bacteriology</source><volume>196</volume><fpage>1723</fpage><lpage>1732</lpage><pub-id pub-id-type="doi">10.1128/JB.01296-13</pub-id><pub-id pub-id-type="pmid">24563035</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laurinavichene</surname><given-names>TV</given-names></name><name><surname>Tsygankov</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>H <sub>2</sub> consumption by <italic>Escherichia coli</italic> coupled via hydrogenase 1 or hydrogenase <sub>2</sub> to different terminal electron acceptors</article-title><source>FEMS Microbiology Letters</source><volume>202</volume><fpage>121</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6968.2001.tb10790.x</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenz</surname><given-names>O</given-names></name><name><surname>Friedrich</surname><given-names>B</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>A novel multicomponent regulatory system mediates H2 sensing in Alcaligenes eutrophus</article-title><source>PNAS</source><volume>95</volume><fpage>12474</fpage><lpage>12479</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.21.12474</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Coupled ferredoxin and crotonyl coenzyme A (CoA) reduction with NADH catalyzed by the butyryl-CoA dehydrogenase/Etf complex from Clostridium kluyveri</article-title><source>Journal of Bacteriology</source><volume>190</volume><fpage>843</fpage><lpage>850</lpage><pub-id pub-id-type="doi">10.1128/JB.01417-07</pub-id><pub-id pub-id-type="pmid">17993531</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Litvak</surname><given-names>Y</given-names></name><name><surname>Byndloss</surname><given-names>MX</given-names></name><name><surname>Bäumler</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Colonocyte metabolism shapes the gut microbiota</article-title><source>Science</source><volume>362</volume><elocation-id>eaat9076</elocation-id><pub-id pub-id-type="doi">10.1126/science.aat9076</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Litvak</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Commensal Enterobacteriaceae Protect against Salmonella Colonization through Oxygen Competition</article-title><source>Cell Host &amp; Microbe</source><volume>25</volume><fpage>128</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2018.12.003</pub-id><pub-id pub-id-type="pmid">30629913</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Virulence factors enhance Citrobacter rodentium expansion through aerobic respiration</article-title><source>Science</source><volume>353</volume><fpage>1249</fpage><lpage>1253</lpage><pub-id pub-id-type="doi">10.1126/science.aag3042</pub-id><pub-id pub-id-type="pmid">27634526</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lukey</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>How <italic>Escherichia coli</italic> is equipped to oxidize hydrogen under different redox conditions</article-title><source>The Journal of Biological Chemistry</source><volume>285</volume><fpage>3928</fpage><lpage>3938</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.067751</pub-id><pub-id pub-id-type="pmid">19917611</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lukey</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Oxygen-tolerant [NiFe]-hydrogenases: the individual and collective importance of supernumerary cysteines at the proximal Fe-S cluster</article-title><source>Journal of the American Chemical Society</source><volume>133</volume><fpage>16881</fpage><lpage>16892</lpage><pub-id pub-id-type="doi">10.1021/ja205393w</pub-id><pub-id pub-id-type="pmid">21916508</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lupp</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae</article-title><source>Cell Host &amp; Microbe</source><volume>2</volume><fpage>119</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2007.06.010</pub-id><pub-id pub-id-type="pmid">18005726</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mai</surname><given-names>V</given-names></name><name><surname>Young</surname><given-names>CM</given-names></name><name><surname>Ukhanova</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Casella</surname><given-names>G</given-names></name><name><surname>Theriaque</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Sharma</surname><given-names>R</given-names></name><name><surname>Hudak</surname><given-names>M</given-names></name><name><surname>Neu</surname><given-names>J</given-names></name><name><surname>Mai</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Fecal microbiota in premature infants prior to necrotizing enterocolitis</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e20647</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0020647</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maier</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Respiratory hydrogen use by <italic>Salmonella enterica</italic> serovar Typhimurium is essential for virulence</article-title><source>Infection and Immunity</source><volume>72</volume><fpage>6294</fpage><lpage>6299</lpage><pub-id pub-id-type="doi">10.1128/IAI.72.11.6294-6299.2004</pub-id><pub-id pub-id-type="pmid">15501756</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maier</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Microbiota-derived hydrogen fuels Salmonella typhimurium invasion of the gut ecosystem</article-title><source>Cell Host &amp; Microbe</source><volume>14</volume><fpage>641</fpage><lpage>651</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2013.11.002</pub-id><pub-id pub-id-type="pmid">24331462</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maier</surname><given-names>L</given-names></name><name><surname>Barthel</surname><given-names>M</given-names></name><name><surname>Stecher</surname><given-names>B</given-names></name><name><surname>Maier</surname><given-names>RJ</given-names></name><name><surname>Gunn</surname><given-names>JS</given-names></name><name><surname>Hardt</surname><given-names>W-D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Salmonella typhimurium strain ATCC14028 requires H2-hydrogenases for growth in the gut, but not at systemic sites</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e110187</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0110187</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manichanh</surname><given-names>R-G</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach</article-title><source>Gut</source><volume>55</volume><fpage>205</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1136/gut.2005.073817</pub-id><pub-id pub-id-type="pmid">16188921</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manichanh</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The gut microbiota in IBD</article-title><source>Nature Reviews. Gastroenterology &amp; Hepatology</source><volume>9</volume><fpage>599</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.1038/nrgastro.2012.152</pub-id><pub-id pub-id-type="pmid">22907164</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mei</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Metagenomic and Metatranscriptomic Analyses Revealed Uncultured Bacteroidales Populations as the Dominant Proteolytic Amino Acid Degraders in Anaerobic Digesters</article-title><source>Frontiers in Microbiology</source><volume>11</volume><elocation-id>593006</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2020.593006</pub-id><pub-id pub-id-type="pmid">33193263</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirsepasi-Lauridsen</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Disease-Specific Enteric Microbiome Dysbiosis in Inflammatory Bowel Disease</article-title><source>Front Med (Lausanne)</source><volume>5</volume><elocation-id>304</elocation-id><pub-id pub-id-type="doi">10.3389/fmed.2018.00304</pub-id><pub-id pub-id-type="pmid">30525037</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>WE</given-names></name><name><surname>Holdeman</surname><given-names>LV</given-names></name></person-group><year iso-8601-date="1974">1974</year><article-title>Human fecal flora: the normal flora of 20 Japanese-Hawaiians</article-title><source>Applied Microbiology</source><volume>27</volume><fpage>961</fpage><lpage>979</lpage><pub-id pub-id-type="doi">10.1128/AM.27.5.961-979.1974</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagao-Kitamoto</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota</article-title><source>Nature Medicine</source><volume>26</volume><fpage>608</fpage><lpage>617</lpage><pub-id pub-id-type="doi">10.1038/s41591-020-0764-0</pub-id><pub-id pub-id-type="pmid">32066975</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Import of Aspartate and Malate by DcuABC Drives H2/Fumarate Respiration to Promote Initial Salmonella Gut-Lumen Colonization in Mice</article-title><source>Cell Host &amp; Microbe</source><volume>27</volume><fpage>922</fpage><lpage>936</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2020.04.013</pub-id><pub-id pub-id-type="pmid">32416061</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olson</surname><given-names>JW</given-names></name><name><surname>Maier</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Molecular hydrogen as an energy source for helicobacter pylori</article-title><source>Science</source><volume>298</volume><fpage>1788</fpage><lpage>1790</lpage><pub-id pub-id-type="doi">10.1126/science.1077123</pub-id><pub-id pub-id-type="pmid">12459589</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panwar</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Influence of the polar light cycle on seasonal dynamics of an Antarctic lake microbial community</article-title><source>Microbiome</source><volume>8</volume><elocation-id>116</elocation-id><pub-id pub-id-type="doi">10.1186/s40168-020-00889-8</pub-id><pub-id pub-id-type="pmid">32772914</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>SJ</given-names></name><name><surname>Andrei</surname><given-names>A-Ş</given-names></name><name><surname>Bulzu</surname><given-names>PA</given-names></name><name><surname>Kavagutti</surname><given-names>VS</given-names></name><name><surname>Ghai</surname><given-names>R</given-names></name><name><surname>Mosier</surname><given-names>AC</given-names></name><name><surname>Park</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Expanded diversity and metabolic versatility of marine nitrite-oxidizing bacteria revealed by Cultivation- and genomics-based approaches</article-title><source>Applied and Environmental Microbiology</source><volume>86</volume><elocation-id>e01667-20</elocation-id><pub-id pub-id-type="doi">10.1128/AEM.01667-20</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>L</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>X-ray crystal structure of the Fe-only hydrogenase (CpI) from Clostridium pasteurianum to 1.8 angstrom resolution</article-title><source>Science</source><volume>282</volume><fpage>1853</fpage><lpage>1858</lpage><pub-id pub-id-type="doi">10.1126/science.282.5395.1853</pub-id><pub-id pub-id-type="pmid">9836629</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piché-Choquette</surname><given-names>S</given-names></name><name><surname>Constant</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Molecular hydrogen, a neglected key driver of soil biogeochemical processes</article-title><source>Applied and Environmental Microbiology</source><volume>85</volume><elocation-id>e02418-18</elocation-id><pub-id pub-id-type="doi">10.1128/AEM.02418-18</pub-id><pub-id pub-id-type="pmid">30658976</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picone</surname><given-names>N</given-names></name><name><surname>Hogendoorn</surname><given-names>C</given-names></name><name><surname>Cremers</surname><given-names>G</given-names></name><name><surname>Poghosyan</surname><given-names>L</given-names></name><name><surname>Pol</surname><given-names>A</given-names></name><name><surname>van Alen</surname><given-names>TA</given-names></name><name><surname>Gagliano</surname><given-names>AL</given-names></name><name><surname>D’Alessandro</surname><given-names>W</given-names></name><name><surname>Quatrini</surname><given-names>P</given-names></name><name><surname>Jetten</surname><given-names>MSM</given-names></name><name><surname>Op den Camp</surname><given-names>HJM</given-names></name><name><surname>Berben</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Geothermal Gases Shape the Microbial Community of the Volcanic Soil of Pantelleria, Italy</article-title><source>MSystems</source><volume>5</volume><elocation-id>e00517-20</elocation-id><pub-id pub-id-type="doi">10.1128/mSystems.00517-20</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinske</surname><given-names>C</given-names></name><name><surname>Sawers</surname><given-names>RG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Anaerobic Formate and Hydrogen Metabolism</article-title><source>EcoSal Plus</source><volume>7</volume><elocation-id>ESP-0011-2016</elocation-id><pub-id pub-id-type="doi">10.1128/ecosalplus.ESP-0011-2016</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Png</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria</article-title><source>The American Journal of Gastroenterology</source><volume>105</volume><fpage>2420</fpage><lpage>2428</lpage><pub-id pub-id-type="doi">10.1038/ajg.2010.281</pub-id><pub-id pub-id-type="pmid">20648002</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Price-Carter</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The alternative electron acceptor tetrathionate supports B12-dependent anaerobic growth of <italic>Salmonella enterica</italic> serovar typhimurium on ethanolamine or 1,2-propanediol</article-title><source>Journal of Bacteriology</source><volume>183</volume><fpage>2463</fpage><lpage>2475</lpage><pub-id pub-id-type="doi">10.1128/JB.183.8.2463-2475.2001</pub-id><pub-id pub-id-type="pmid">11274105</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rey</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Metabolic niche of a prominent sulfate-reducing human gut bacterium</article-title><source>PNAS</source><volume>110</volume><fpage>13582</fpage><lpage>13587</lpage><pub-id pub-id-type="doi">10.1073/pnas.1312524110</pub-id><pub-id pub-id-type="pmid">23898195</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richard</surname><given-names>DJ</given-names></name><name><surname>Sargent</surname><given-names>F</given-names></name><name><surname>Sawers</surname><given-names>G</given-names></name><name><surname>McWalter</surname><given-names>L</given-names></name><name><surname>Boxer</surname><given-names>DH</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Transcriptional regulation in response to oxygen and nitrate of the operons encoding the (NIFE) hydrogenases 1 and 2 of <italic>Escherichia coli</italic></article-title><source>Microbiology</source><volume>145</volume><fpage>2903</fpage><lpage>2912</lpage><pub-id pub-id-type="doi">10.1099/00221287-145-10-2903</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivera-Chavez</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Depletion of Butyrate-Producing Clostridia from the Gut Microbiota Drives an Aerobic Luminal Expansion of Salmonella</article-title><source>Cell Host &amp; Microbe</source><volume>19</volume><fpage>443</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2016.03.004</pub-id><pub-id pub-id-type="pmid">27078066</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruaud</surname><given-names>A</given-names></name><name><surname>Esquivel-Elizondo</surname><given-names>S</given-names></name><name><surname>de la Cuesta-Zuluaga</surname><given-names>J</given-names></name><name><surname>Waters</surname><given-names>JL</given-names></name><name><surname>Angenent</surname><given-names>LT</given-names></name><name><surname>Youngblut</surname><given-names>ND</given-names></name><name><surname>Ley</surname><given-names>RE</given-names></name><name><surname>Ruaud</surname><given-names>E-E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Syntrophy via Interspecies H <sub>2</sub> Transfer between <italic>Christensenella</italic> and <italic>Methanobrevibacter</italic> Underlies Their Global Cooccurrence in the Human Gut</article-title><source>mBio</source><volume>11</volume><elocation-id>11</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.03235-19</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samuel</surname><given-names>BS</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism</article-title><source>PNAS</source><volume>103</volume><fpage>10011</fpage><lpage>10016</lpage><pub-id pub-id-type="doi">10.1073/pnas.0602187103</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samuel</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Genomic and metabolic adaptations of Methanobrevibacter smithii to the human gut</article-title><source>PNAS</source><volume>104</volume><fpage>10643</fpage><lpage>10648</lpage><pub-id pub-id-type="doi">10.1073/pnas.0704189104</pub-id><pub-id pub-id-type="pmid">17563350</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schubert</surname><given-names>C</given-names></name><name><surname>Winter</surname><given-names>M</given-names></name><name><surname>Ebert-Jung</surname><given-names>A</given-names></name><name><surname>Kierszniowska</surname><given-names>S</given-names></name><name><surname>Nagel-Wolfrum</surname><given-names>K</given-names></name><name><surname>Schramm</surname><given-names>T</given-names></name><name><surname>Link</surname><given-names>H</given-names></name><name><surname>Winter</surname><given-names>S</given-names></name><name><surname>Unden</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>C4-dicarboxylates and l-aspartate utilization by <italic>Escherichia coli</italic> k-12 in the mouse intestine: L-aspartate as a major substrate for fumarate respiration and as a nitrogen source</article-title><source>Environmental Microbiology</source><volume>23</volume><fpage>2564</fpage><lpage>2577</lpage><pub-id pub-id-type="doi">10.1111/1462-2920.15478</pub-id><pub-id pub-id-type="pmid">33754467</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schut</surname><given-names>GJ</given-names></name><name><surname>Adams</surname><given-names>MWW</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The iron-hydrogenase of Thermotoga maritima utilizes ferredoxin and NADH synergistically: a new perspective on anaerobic hydrogen production</article-title><source>Journal of Bacteriology</source><volume>191</volume><fpage>4451</fpage><lpage>4457</lpage><pub-id pub-id-type="doi">10.1128/JB.01582-08</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sellon</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice</article-title><source>Infection and Immunity</source><volume>66</volume><fpage>5224</fpage><lpage>5231</lpage><pub-id pub-id-type="doi">10.1128/IAI.66.11.5224-5231.1998</pub-id><pub-id pub-id-type="pmid">9784526</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shima</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The crystal structure of [Fe]-hydrogenase reveals the geometry of the active site</article-title><source>Science</source><volume>321</volume><fpage>572</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1126/science.1158978</pub-id><pub-id pub-id-type="pmid">18653896</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>R</given-names></name><name><surname>Priefer</surname><given-names>U</given-names></name><name><surname>Pühler</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1983">1983</year><article-title>A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram negative bacteria</article-title><source>Bio/Technology</source><volume>1</volume><fpage>784</fpage><lpage>791</lpage><pub-id pub-id-type="doi">10.1038/nbt1183-784</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease</article-title><source>Gastroenterology</source><volume>111</volume><fpage>871</fpage><lpage>885</lpage><pub-id pub-id-type="doi">10.1016/s0016-5085(96)70055-0</pub-id><pub-id pub-id-type="pmid">8831582</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Hydrogen cross-feeders of the human gastrointestinal tract</article-title><source>Gut Microbes</source><volume>10</volume><fpage>270</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1080/19490976.2018.1546522</pub-id><pub-id pub-id-type="pmid">30563420</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Søndergaard</surname><given-names>D</given-names></name><name><surname>Pedersen</surname><given-names>CNS</given-names></name><name><surname>Greening</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Hyddb: A web tool for hydrogenase classification and analysis</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>34212</elocation-id><pub-id pub-id-type="doi">10.1038/srep34212</pub-id><pub-id pub-id-type="pmid">27670643</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spandidos</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A comprehensive collection of experimentally validated primers for Polymerase Chain Reaction quantitation of murine transcript abundance</article-title><source>BMC Genomics</source><volume>9</volume><elocation-id>633</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2164-9-633</pub-id><pub-id pub-id-type="pmid">19108745</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spandidos</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Seed</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Primerbank: A resource of human and mouse pcr primer pairs for gene expression detection and quantification</article-title><source>Nucleic Acids Research</source><volume>38</volume><fpage>D792</fpage><lpage>D799</lpage><pub-id pub-id-type="doi">10.1093/nar/gkp1005</pub-id><pub-id pub-id-type="pmid">19906719</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spiga</surname><given-names>L</given-names></name><name><surname>Winter</surname><given-names>SE</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Using enteric pathogens to probe the gut microbiota</article-title><source>Trends in Microbiology</source><volume>27</volume><fpage>243</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2018.11.007</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stairs</surname><given-names>CW</given-names></name><name><surname>Dharamshi</surname><given-names>JE</given-names></name><name><surname>Tamarit</surname><given-names>D</given-names></name><name><surname>Eme</surname><given-names>L</given-names></name><name><surname>Jørgensen</surname><given-names>SL</given-names></name><name><surname>Spang</surname><given-names>A</given-names></name><name><surname>Ettema</surname><given-names>TJG</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Chlamydial contribution to anaerobic metabolism during eukaryotic evolution</article-title><source>Science Advances</source><volume>6</volume><elocation-id>eabb7258</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.abb7258</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stams</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Metabolic interactions between anaerobic bacteria in methanogenic environments</article-title><source>Antonie van Leeuwenhoek</source><volume>66</volume><fpage>271</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1007/BF00871644</pub-id><pub-id pub-id-type="pmid">7747937</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stecher</surname><given-names>B</given-names></name><name><surname>Robbiani</surname><given-names>R</given-names></name><name><surname>Walker</surname><given-names>AW</given-names></name><name><surname>Westendorf</surname><given-names>AM</given-names></name><name><surname>Barthel</surname><given-names>M</given-names></name><name><surname>Kremer</surname><given-names>M</given-names></name><name><surname>Chaffron</surname><given-names>S</given-names></name><name><surname>Macpherson</surname><given-names>AJ</given-names></name><name><surname>Buer</surname><given-names>J</given-names></name><name><surname>Parkhill</surname><given-names>J</given-names></name><name><surname>Dougan</surname><given-names>G</given-names></name><name><surname>von Mering</surname><given-names>C</given-names></name><name><surname>Hardt</surname><given-names>WD</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title><italic>Salmonella enterica</italic> serovar typhimurium exploits inflammation to compete with the intestinal microbiota</article-title><source>PLOS Biology</source><volume>5</volume><elocation-id>2177</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.0050244</pub-id><pub-id pub-id-type="pmid">17760501</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamagnini</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Cyanobacterial hydrogenases: diversity, regulation and applications</article-title><source>FEMS Microbiology Reviews</source><volume>31</volume><fpage>692</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6976.2007.00085.x</pub-id><pub-id pub-id-type="pmid">17903205</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tigchelaar</surname><given-names>EF</given-names></name><name><surname>Zhernakova</surname><given-names>A</given-names></name><name><surname>Dekens</surname><given-names>JAM</given-names></name><name><surname>Hermes</surname><given-names>G</given-names></name><name><surname>Baranska</surname><given-names>A</given-names></name><name><surname>Mujagic</surname><given-names>Z</given-names></name><name><surname>Swertz</surname><given-names>MA</given-names></name><name><surname>Muñoz</surname><given-names>AM</given-names></name><name><surname>Deelen</surname><given-names>P</given-names></name><name><surname>Cénit</surname><given-names>MC</given-names></name><name><surname>Franke</surname><given-names>L</given-names></name><name><surname>Scholtens</surname><given-names>S</given-names></name><name><surname>Stolk</surname><given-names>RP</given-names></name><name><surname>Wijmenga</surname><given-names>C</given-names></name><name><surname>Feskens</surname><given-names>EJM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cohort profile: lifelines deep, a prospective, general population cohort study in the Northern Netherlands: study design and baseline characteristics</article-title><source>BMJ Open</source><volume>5</volume><elocation-id>e006772</elocation-id><pub-id pub-id-type="doi">10.1136/bmjopen-2014-006772</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unden</surname><given-names>G</given-names></name><name><surname>Steinmetz</surname><given-names>PA</given-names></name><name><surname>Degreif-Dünnwald</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The aerobic and anaerobic respiratory chain of <italic>Escherichia coli</italic> and <italic>Salmonella enterica</italic>: Enzymes and energetics</article-title><source>EcoSal Plus</source><volume>3</volume><elocation-id>ecosalplus.3.2.2</elocation-id><pub-id pub-id-type="doi">10.1128/ecosalplus.ESP-0005-2013</pub-id><pub-id pub-id-type="pmid">26442941</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vignais</surname><given-names>PM</given-names></name><name><surname>Billoud</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Occurrence, classification, and biological function of hydrogenases: an overview</article-title><source>Chemical Reviews</source><volume>107</volume><fpage>4206</fpage><lpage>4272</lpage><pub-id pub-id-type="doi">10.1021/cr050196r</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volbeda</surname><given-names>A</given-names></name><name><surname>Amara</surname><given-names>P</given-names></name><name><surname>Darnault</surname><given-names>C</given-names></name><name><surname>Mouesca</surname><given-names>JM</given-names></name><name><surname>Parkin</surname><given-names>A</given-names></name><name><surname>Roessler</surname><given-names>MM</given-names></name><name><surname>Armstrong</surname><given-names>FA</given-names></name><name><surname>Fontecilla-Camps</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>X-ray crystallographic and computational studies of the o2-tolerant (NIFE)-hydrogenase 1 from <italic>Escherichia coli</italic></article-title><source>PNAS</source><volume>109</volume><fpage>5305</fpage><lpage>5310</lpage><pub-id pub-id-type="doi">10.1073/pnas.1119806109</pub-id><pub-id pub-id-type="pmid">22431599</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volbeda</surname><given-names>A</given-names></name><name><surname>Darnault</surname><given-names>C</given-names></name><name><surname>Parkin</surname><given-names>A</given-names></name><name><surname>Sargent</surname><given-names>F</given-names></name><name><surname>Armstrong</surname><given-names>FA</given-names></name><name><surname>Fontecilla-Camps</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Crystal structure of the O(2)-tolerant membrane-bound hydrogenase 1 from <italic>Escherichia coli</italic> in complex with its cognate cytochrome b</article-title><source>Structure</source><volume>21</volume><fpage>184</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/j.str.2012.11.010</pub-id><pub-id pub-id-type="pmid">23260654</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>RF</given-names></name><name><surname>Kushner</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Construction of versatile low-copy-number vectors for cloning, sequencing and gene expression in <italic>Escherichia coli</italic></article-title><source>Gene</source><volume>100</volume><fpage>195</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1016/0378-1119(91)90366-J</pub-id><pub-id pub-id-type="pmid">2055470</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Seed</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>A PCR primer bank for quantitative gene expression analysis</article-title><source>Nucleic Acids Research</source><volume>31</volume><elocation-id>e154</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gng154</pub-id><pub-id pub-id-type="pmid">14654707</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>El-Fahmawi</surname><given-names>A</given-names></name><name><surname>Christian</surname><given-names>DA</given-names></name><name><surname>Fang</surname><given-names>Q</given-names></name><name><surname>Radaelli</surname><given-names>E</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Sullivan</surname><given-names>MC</given-names></name><name><surname>Misic</surname><given-names>AM</given-names></name><name><surname>Ellringer</surname><given-names>JA</given-names></name><name><surname>Zhu</surname><given-names>X-Q</given-names></name><name><surname>Winter</surname><given-names>SE</given-names></name><name><surname>Hunter</surname><given-names>CA</given-names></name><name><surname>Beiting</surname><given-names>DP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Infection-induced intestinal dysbiosis is mediated by macrophage activation and nitrate production</article-title><source>MBio</source><volume>10</volume><elocation-id>e00935-19</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.00935-19</pub-id><pub-id pub-id-type="pmid">31138751</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weerakoon</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The role of respiratory donor enzymes in Campylobacter jejuni host colonization and physiology</article-title><source>Microbial Pathogenesis</source><volume>47</volume><fpage>8</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2009.04.009</pub-id><pub-id pub-id-type="pmid">19397993</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The Vi-capsule prevents Toll-like receptor 4 recognition of Salmonella</article-title><source>Cellular Microbiology</source><volume>10</volume><fpage>876</fpage><lpage>890</lpage><pub-id pub-id-type="doi">10.1111/j.1462-5822.2007.01090.x</pub-id><pub-id pub-id-type="pmid">18034866</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winter</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Gut inflammation provides a respiratory electron acceptor for Salmonella</article-title><source>Nature</source><volume>467</volume><fpage>426</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1038/nature09415</pub-id><pub-id pub-id-type="pmid">20864996</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winter</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Host-derived nitrate boosts growth of <italic>E. coli</italic> in the inflamed gut</article-title><source>Science</source><volume>339</volume><fpage>708</fpage><lpage>711</lpage><pub-id pub-id-type="doi">10.1126/science.1232467</pub-id><pub-id pub-id-type="pmid">23393266</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winter</surname><given-names>SE</given-names></name><name><surname>Bäumler</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Dysbiosis in the inflamed intestine: Chance favors the prepared microbe</article-title><source>Gut Microbes</source><volume>5</volume><fpage>71</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.4161/gmic.27129</pub-id><pub-id pub-id-type="pmid">24637596</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>H2 metabolism is widespread and diverse among human colonic microbes</article-title><source>Gut Microbes</source><volume>7</volume><fpage>235</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1080/19490976.2016.1182288</pub-id><pub-id pub-id-type="pmid">27123663</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Microbial dark matter filling the niche in hypersaline microbial mats</article-title><source>Microbiome</source><volume>8</volume><elocation-id>135</elocation-id><pub-id pub-id-type="doi">10.1186/s40168-020-00910-0</pub-id><pub-id pub-id-type="pmid">32938503</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>I</given-names></name><name><surname>Ishimoto</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1978">1978</year><article-title>Hydrogen-dependent growth of <italic>Escherichia coli</italic> in anaerobic respiration and the presence of hydrogenases with different functions</article-title><source>The Journal of Biochemistry</source><volume>84</volume><fpage>673</fpage><lpage>679</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.jbchem.a132172</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Gurry</surname><given-names>T</given-names></name><name><surname>Nguyen</surname><given-names>LTT</given-names></name><name><surname>Richardson</surname><given-names>HS</given-names></name><name><surname>Alm</surname><given-names>EJ</given-names></name><name><surname>Yu</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Prebiotics and community composition influence gas production of the human gut microbiota</article-title><source>MBio</source><volume>11</volume><elocation-id>11</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.00217-20</pub-id><pub-id pub-id-type="pmid">32900799</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Precision editing of the gut microbiota ameliorates colitis</article-title><source>Nature</source><volume>553</volume><fpage>208</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1038/nature25172</pub-id><pub-id pub-id-type="pmid">29323293</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="keyresource" position="anchor"><label><bold>Appendix 1—key resources table</bold></label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">C57BL/6</td><td align="left" valign="bottom">Jackson Laboratory or bred at UT Southwestern (originally from Jackson Laboratory)</td><td align="left" valign="bottom">Jackson Laboratory Cat# 000664</td><td align="left" valign="bottom">Wild-type</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Il10</italic><sup>-/-</sup> C57BL/6</td><td align="left" valign="bottom">Bred at UT Southwestern (originally from Jackson Laboratory)</td><td align="left" valign="bottom">Jackson Laboratory Cat# 002251</td><td align="left" valign="bottom">B6.129P2-<italic>Il10<sup>tm1Cgn</sup></italic>/J</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Il10</italic><sup>-/-</sup> BALB/c</td><td align="left" valign="bottom">Bred at UT Southwestern (originally from Jackson Laboratory)</td><td align="left" valign="bottom">Jackson Laboratory Cat# 004333</td><td align="left" valign="bottom">C.129P2(B6)<italic>-Il10<sup>tm1Cgn</sup></italic>/J</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>Escherichia coli</italic>)</td><td align="left" valign="bottom">Nissle 1917 (EcN)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib27">Grozdanov, 2004</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Wild-type strain (O6:K5:H1)</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>E. coli</italic>)</td><td align="left" valign="bottom">S17-1 λ<italic>pir</italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib86">Simon et al., 1983</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>zxx</italic>::RP4 2-(Tet<sup>r</sup>::Mu) (Kan<sup>r</sup>::Tn7) λ<italic>pir</italic></td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>E. coli</italic>)</td><td align="left" valign="bottom">EL5</td><td align="left" valign="bottom">This study; Winter lab, UT Southwestern</td><td align="left" valign="bottom"/><td align="left" valign="bottom">EcN Δ<italic>hyaABC</italic></td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>E. coli</italic>)</td><td align="left" valign="bottom">EL11</td><td align="left" valign="bottom">This study; Winter lab, UT Southwestern</td><td align="left" valign="bottom"/><td align="left" valign="bottom">EcN Δ<italic>hybABC</italic></td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>E. coli</italic>)</td><td align="left" valign="bottom">EL15</td><td align="left" valign="bottom">This study; Winter lab, UT Southwestern</td><td align="left" valign="bottom"/><td align="left" valign="bottom">EcN Δ<italic>hyaABC</italic> Δ<italic>hybABC</italic></td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>E. coli</italic>)</td><td align="left" valign="bottom">EL252</td><td align="left" valign="bottom">This study; Winter lab, UT Southwestern</td><td align="left" valign="bottom"/><td align="left" valign="bottom">MP1 Δ<italic>hyaABC</italic></td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>E. coli</italic>)</td><td align="left" valign="bottom">EL276</td><td align="left" valign="bottom">This study; Winter lab, UT Southwestern</td><td align="left" valign="bottom"/><td align="left" valign="bottom">MP1 Δ<italic>hyaABC</italic> Δ<italic>hybABC</italic></td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>E. coli</italic>)</td><td align="left" valign="bottom">EL284</td><td align="left" valign="bottom">This study; Winter lab, UT Southwestern</td><td align="left" valign="bottom"/><td align="left" valign="bottom">EcNΔ<italic>narG</italic>Δ<italic>napA</italic>Δ<italic>narZ</italic>Δ<italic>hyaABC</italic> Δ<italic>hybABC</italic></td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>E. coli</italic>)</td><td align="left" valign="bottom">EL347</td><td align="left" valign="bottom">This study; Winter lab, UT Southwestern</td><td align="left" valign="bottom"/><td align="left" valign="bottom">EcNΔ<italic>frdABCD</italic></td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>E. coli</italic>)</td><td align="left" valign="bottom">EL350</td><td align="left" valign="bottom">This study; Winter lab, UT Southwestern</td><td align="left" valign="bottom"/><td align="left" valign="bottom">EcNΔ<italic>frdABCD</italic>Δ<italic>hyaABC</italic> Δ<italic>hybABC</italic></td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>E. coli</italic>)</td><td align="left" valign="bottom">EL363</td><td align="left" valign="bottom">This study; Winter lab, UT Southwestern</td><td align="left" valign="bottom"/><td align="left" valign="bottom">EcNΔ<italic>appC</italic>Δ<italic>hyaABC</italic> Δ<italic>hybABC</italic></td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>E. coli</italic>)</td><td align="left" valign="bottom">MW139</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib11">Chanin, 2020</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">EcNΔ<italic>appC</italic></td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>E. coli</italic>)</td><td align="left" valign="bottom">SW930</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib108">Winter, 2013</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">EcNΔ<italic>narG</italic>Δ<italic>napA</italic>Δ<italic>narZ</italic></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEL1</td><td align="left" valign="bottom">This study; Winter lab, UT Southwestern</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Upstream and downstream regions of EcN <italic>hyaABC</italic> in pRDH10</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEL2</td><td align="left" valign="bottom">This study; Winter lab, UT Southwestern</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Upstream and downstream regions of EcN <italic>hybABC</italic> in pRDH10</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEL29</td><td align="left" valign="bottom">This study; Winter lab, UT Southwestern</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Upstream and downstream regions of MP1 <italic>hyaABC</italic> in pGP706</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEL30</td><td align="left" valign="bottom">This study; Winter lab, UT Southwestern</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Upstream and downstream regions of MP1 <italic>hybABC</italic> in pGP706</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEL32</td><td align="left" valign="bottom">This study; Winter lab, UT Southwestern</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Promoter and coding sequence of EcN <italic>hybABC</italic> in pWSK129</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pEL35</td><td align="left" valign="bottom">This study; Winter lab, UT Southwestern</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Upstream and downstream regions of EcN <italic>frdABCD</italic> in pGP706</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pGP706</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib31">Hughes, 2017</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>ori</italic>(R6K) <italic>mobRP4 sacRB</italic> Kan<sup>r</sup></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pRDH10</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib38">Kingsley, 1999</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>ori</italic>(R6K) <italic>mobRP4 sacRB</italic> Tet<sup>r</sup> Cm<sup>r</sup></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pSW172</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib108">Winter, 2013</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>ori</italic>(R101) <italic>repA101ts</italic> Carb<sup>r</sup></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pSW296</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib11">Chanin, 2020</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Upstream and downstream regions of EcN <italic>appC</italic> in pRDH10</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pWSK129</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib102">Wang and Kushner, 1991</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>ori</italic>(pSC101) Kan<sup>r</sup></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pWSK29</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib102">Wang and Kushner, 1991</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>ori</italic>(pSC101) Carb<sup>r</sup></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Primers used for mutagenesis</td><td align="left" valign="bottom">This study; Winter lab, UT Southwestern</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">Primers used for mutagenesis in this study are listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mouse <italic>GapDH</italic> RT-qPCR Forward Primer</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib90">Spandidos, 2008</xref>; <xref ref-type="bibr" rid="bib91">Spandidos et al., 2010</xref>; <xref ref-type="bibr" rid="bib103">Wang and Seed, 2003</xref></td><td align="left" valign="bottom">Primer Bank ID 6679937a1</td><td align="left" valign="bottom">AGGTCGGTGTGAACGGATTTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>GapDH</italic> RT-qPCR Reverse Primer</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib90">Spandidos, 2008</xref>; <xref ref-type="bibr" rid="bib91">Spandidos et al., 2010</xref>; <xref ref-type="bibr" rid="bib103">Wang and Seed, 2003</xref></td><td align="left" valign="bottom">Primer Bank ID 6679937a1</td><td align="left" valign="bottom">TGTAGACCATGTAGTTGAGGTCA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Cxcl1</italic> RT-qPCR Primer</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib25">Godinez, 2008</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">TGCACCCAAACCGAAGTCAT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Cxcl1</italic> RT-qPCR Primer</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib25">Godinez, 2008</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">TTGTCAGAAGCCAGCGTTCAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Nos2</italic> RT-qPCR Primer</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib25">Godinez, 2008</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">TTGGGTCTTGTTCACTCCACGG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Nos2</italic> RT-qPCR Primer</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib25">Godinez, 2008</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">CCTCTTTCAGGTCACTTTGGTAGG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Mouse <italic>Tnfa</italic> RT-qPCR Forward Primer</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib106">Wilson, 2008</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">AGCCAGGAGGGAGAACAGAAAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mouse <italic>Tnfa</italic> RT-qPCR Primer</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib106">Wilson, 2008</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">CCAGTGAGTGAAAGGGACAGAACC</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Gibson Assembly Master Mix</td><td align="left" valign="bottom">New England Biolabs</td><td align="left" valign="bottom">Cat# E2611</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Q5 Hot Start 2 x Master Mix</td><td align="left" valign="bottom">New England Biolabs</td><td align="left" valign="bottom">Cat# M0494</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">QIAfilter Plasmid Midi Kit</td><td align="left" valign="bottom">QIAGEN</td><td align="left" valign="bottom">Cat# 12245</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">QIAEX II Gel Extraction Kit</td><td align="left" valign="bottom">QIAGEN</td><td align="left" valign="bottom">Cat# 20021</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">TRI Reagent</td><td align="left" valign="bottom">Molecular Research Center</td><td align="left" valign="bottom">Cat# TR118</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">NEBNext Poly(A) mRNA Magnetic Isolation Module</td><td align="left" valign="bottom">New England Biolabs</td><td align="left" valign="bottom">Cat# E7490</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">TaqMan Reverse Transcription Reagents</td><td align="left" valign="bottom">Applied Biosystems</td><td align="left" valign="bottom">Cat# N8080234</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">SYBR Green qPCR Master Mix</td><td align="left" valign="bottom">Applied Biosystems</td><td align="left" valign="bottom">Cat# 4309155</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Mucin from porcine stomach, Type II</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat# M2378</td><td align="left" valign="bottom">Lot#SLCD8300</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Sodium nitrate</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat# S5506</td><td align="left" valign="bottom">Lot# MKCC4317</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Sodium fumurate dibasic</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat# F1506</td><td align="left" valign="bottom">Lot#BCCC8774</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Dextran sulfate sodium salt, MW ca 40,000</td><td align="left" valign="bottom">Alfa Aesar</td><td align="left" valign="bottom">Cat# J63606</td><td align="left" valign="bottom">Lots# T17A050, U03C023, S13C040, U01F027</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Piroxicam diet(50 ppm, 100 ppm)</td><td align="left" valign="bottom">Envigo</td><td align="left" valign="bottom">Custom diet</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">LB Broth, Miller (Luria Bertani)</td><td align="left" valign="bottom">Becton Dickinson</td><td align="left" valign="bottom">Cat# 244620</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Kanamycin sulfate</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Cat# BP906</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Chloramphenicol</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Cat# BP904</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Carbenicillin, disodium salt</td><td align="left" valign="bottom">VWR</td><td align="left" valign="bottom">Cat# J358</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Excel</td><td align="left" valign="bottom">Microsoft Office</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.microsoft.com/en-us/microsoft-365/excel">https://www.microsoft.com/en-us/microsoft-365/excel</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Prism v9.0</td><td align="left" valign="bottom">GraphPad</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/scientific-software/prism/">https://www.graphpad.com/scientific-software/prism/</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">MacVector</td><td align="left" valign="bottom">MacVector</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://macvector.com/">https://macvector.com/</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">QuantStudio 6</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.thermofisher.com/us/en/home/life-science/pcr/real-time-pcr/real-time-pcr-instruments/quantstudio-systems/models/quantstudio-6-7-flex.html">https://www.thermofisher.com/us/en/home/life-science/pcr/real-time-pcr/real-time-pcr-instruments/quantstudio-systems/models/quantstudio-6-7-flex.html</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">BioRender</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.BioRender.com">https://www.BioRender.com</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">PowerPoint</td><td align="left" valign="bottom">Microsoft Office</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.microsoft.com/en-us/microsoft-365/powerpoint">https://www.microsoft.com/en-us/microsoft-365/powerpoint</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">BBMap software suite</td><td align="left" valign="bottom">Joint Genome Institute</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://jgi.doe.gov/data-and-tools/bbtools/">https://jgi.doe.gov/data-and-tools/bbtools/</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Bowtie 2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib44">Langmead and Salzberg, 2012</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://bowtie-bio.sourceforge.net/bowtie2/index.shtml">http://bowtie-bio.sourceforge.net/bowtie2/index.shtml</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">DIAMOND</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib9">Buchfink, 2015</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/bbuchfink/diamond">https://github.com/bbuchfink/diamond</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">MEGAN5</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib32">Huson, 2007</xref>; <xref ref-type="bibr" rid="bib33">Huson et al., 2016</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://software-ab.informatik.uni-tuebingen.de/download/megan5/welcome.html">https://software-ab.informatik.uni-tuebingen.de/download/megan5/welcome.html</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">FMAP</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib37">Kim, 2016</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/jiwoongbio/FMAP">https://github.com/jiwoongbio/FMAP</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">DESeq2</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib52">Love, 2014</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/release/bioc/html/DESeq2.html">https://bioconductor.org/packages/release/bioc/html/DESeq2.html</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ART</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib30">Huang, 2012</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.niehs.nih.gov/research/resources/software/biostatistics/art/index.cfm">https://www.niehs.nih.gov/research/resources/software/biostatistics/art/index.cfm</ext-link></td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Anaerobic Chamber</td><td align="left" valign="bottom">Sheldon Manufacturing</td><td align="left" valign="bottom">Bactron300</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">European Nucleotide Archive, accession number PRJEB15095</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib31">Hughes, 2017</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Metagenomic sequencing of cecal microbiota from DSS colitis mouse model</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">SRA, BioProject number PRJNA400072</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib22">Franzosa, 2019</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Human gut metagenome</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">HydDB Hydrogenase Database</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib89">Søndergaard et al., 2016</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.58609.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Turnbaugh</surname><given-names>Peter</given-names></name><role>Reviewing Editor</role><aff><institution>University of California, San Francisco</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Turnbaugh</surname><given-names>Peter</given-names></name><role>Reviewer</role><aff><institution>University of California, San Francisco</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>Hydrogen metabolism is important for infectious disease agents, but its role in chronic diseases like inflammatory bowel disease remain unclear. In this report, Hughes et al. analyze human microbiome data and use mouse models to demonstrate that hydrogenases are important for fitness in the inflamed gut, suggesting that hydrogen metabolism may contribute to bacterial overgrowth during colitis.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Reshaping of bacterial molecular hydrogen metabolism contributes to inflammation-associated gut microbiota dysbiosis&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, including Peter Turnbaugh as the Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Wendy Garrett as the Senior Editor.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>As the editors have judged that your manuscript is of interest, but as described below that additional experiments are required before it is published, we would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). First, because many researchers have temporarily lost access to the labs, we will give authors as much time as they need to submit revised manuscripts. We are also offering, if you choose, to post the manuscript to bioRxiv (if it is not already there) along with this decision letter and a formal designation that the manuscript is &quot;in revision at <italic>eLife</italic>&quot;. Please let us know if you would like to pursue this option. (If your work is more suitable for medRxiv, you will need to post the preprint yourself, as the mechanisms for us to do so are still in development.)</p><p>Summary:</p><p>Hughes et al. investigate the role of hydrogen utilization by <italic>E. coli</italic> during colitis. They analyze previously published metagenomic datasets in humans and in mice to identify bacterial hydrogenases as factors that are increased during colitis. With a series of elegant in vivo experiments, by using a DSS colitis model and an IL10 colitis model, they demonstrate that hydrogenases are important for fitness in the inflamed gut for both a mouse and a human <italic>E. coli</italic> isolate. Overall, this is an important and well-conducted study, which nicely demonstrates the importance of hydrogen metabolism for bacterial overgrowth during colitis. The experiments are well designed and conducted, and carefully interpreted. The study fits well with the literature demonstrating a role for hydrogenases during infection with pathogens, but for the first time it shows their importance also for metabolism of non-pathogenic strains in inflammatory conditions.</p><p>Essential revisions:</p><p>1. The bioinformatics analysis is well motivated but could use a lot more work and details. The methods are unclear as to what cutoffs are used. There's no discussion of any controls that were run or prior data indicating the reliability of the hydrogenase annotations. The re-analysis of the human and mouse data did not adjust for multiple hypotheses. More importantly, gene abundance is analyzed without accounting for the increased abundance of <italic>Enterobacteriaceae</italic> in colitis, which could easily explain the observed gene-level enrichments. As is, I'm unconvinced that there is an association between IBD and hydrogenase abundance or the specific enrichment of &quot;uptake hydrogenases&quot;.</p><p>2. Another major issue in my opinion is the conceptual framing around &quot;dysbiosis&quot;, which is a problematic term due to its inconsistent use in the scientific literature but nonetheless implies some sort of overall shift in gut microbial community structure. That isn't really tested here, all of the experiments show competitive growth between artificial mutants and wild-type <italic>E. coli</italic>. There's also only a single experiment (Figure 4) that include healthy controls, making it impossible to determine if the expansion of <italic>E. coli</italic> is impacted by the loss of hya and/or hyb. Figure 4c,d shows that the double KO is still able to expand in DSS treated mice, conflicting with the hypothesis that hydrogen metabolism is required for dysbiosis. On a related note, the authors should discuss the alternative hypothesis that dysbiosis occurs prior to colitis. The assumption herein is that inflammation drives a shift in the microenvironment's redox potential which then shifts the gut microbiota. More citations are needed to explain the rationale and current evidence in support of these two alternative hypotheses in humans and mouse models. One simple experiment that could be done to address the author's dysbiosis hypothesis would be to colonize mice with a single strain at a time. Can the double KO still expand in the absence of wild-type? Does it reach a lower abundance than wild-type in mono-colonization?</p><p>3. While the genetics shows that this operon matters in vivo, there's no real data supporting whether or not hydrogenase activity is responsible, either in vitro or in vivo. Ideally additional assays and/or experiments could be added to provide support for the metabolic consequences of these deletions. At a minimum, this caveat needs to be added to the discussion and the authors should be careful not to imply that the activity matters (just that the operons do). Key controls are also missing for the bacterial genetics, including comparisons of the KO and wild-type strains during in vitro growth and complementation.</p><p>4. There is little insight into how mechanistically these hydrogenases may provide a growth advantage in the intestine, and specifically what it is about inflammation that makes Hyd-1 and Hyd-2 important? For example, how does DSS-induced weight loss change in <italic>Enterobacteriaceae</italic>-free (Jax B6) mice vs. those colonized with MP1 or EcN strains of <italic>E. coli</italic>? One might infer that EcN induces less inflammation than MP1, based upon Figure 2B vs. D, but there is no control group without <italic>E. coli</italic> to compare to. This leads me to the next example, which is Figure 5 piroxican Il10-/- experiments. Although the body weight of Il10-/- BALB/c mice on piroxicam is only minimally reduced (indicating less inflammation) compared to the Il10-/- C57BL/6 model, the EcN and MP1 bloom is still statistically significant. It is an oversimplification to conclude that Hyd-1 and Hyd-2 are important during &quot;inflammation,&quot; as weight loss is the only measure of inflammation and differs between mouse strains and models. I recommend additional controls for each of these models, including DSS or piroxicam with no <italic>E. coli</italic> colonization, and knockout strains evaluated in the presence and absence of inflammation (i.e. no DSS to demonstrate Hyd-1 and Hyd-2 are not important under homeostatic conditions). Furthermore, there should be greater analysis into what aspect of inflammation makes Hyd-1 and Hyd-2 important for bacterial bloom – is there a direct correlation between extent of weight loss? Is there an immune cell type, cytokine signature, or histologic feature that makes Hyd-1 and Hyd-2 important? The spread of data in Figure 5 shows it would be possible to tease this apart.</p><p>5. Male and female mice were used in these experiments. DSS has a known sex difference. The authors must indicate the sex of the mice and test to see if sex could be responsible for the observed changes.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.58609.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>1. The bioinformatics analysis is well motivated but could use a lot more work and details. The methods are unclear as to what cutoffs are used. There's no discussion of any controls that were run or prior data indicating the reliability of the hydrogenase annotations. The re-analysis of the human and mouse data did not adjust for multiple hypotheses. More importantly, gene abundance is analyzed without accounting for the increased abundance of Enterobacteriaceae in colitis, which could easily explain the observed gene-level enrichments. As is, I'm unconvinced that there is an association between IBD and hydrogenase abundance or the specific enrichment of &quot;uptake hydrogenases&quot;.</p></disp-quote><p>We thank the reviewers for their constructive feedback regarding the bioinformatics analysis. The reviewer raises several points, which we have addressed as follows:</p><p>We have updated the methods section to include specific cutoff values that were used.</p><p>In our analyses, the hydrogenase annotations with predicted activities were based on the HydDB database (Sondergaard et al., 2016), which has been widely utilized to classify hydrogenases (Dong et al., 2020; Mei et al., 2020; Panwar et al., 2020; Park et al., 2020; Picone et al., 2020; Stairs et al., 2020; Wong et al., 2020; Yu et al., 2020).</p><p>To assess the reliability of the hydrogenase annotations in the HydDB database, we aligned simulated metagenomic datasets of hydrogenase-containing and hydrogenase-free genomes to the HydDB database and compared the relative abundance of mapped reads between datasets. Genomes of five representative members of the gut microbiome were utilized. The hydrogenase-free genomes were generated by removing sequences of all known hydrogenases from the corresponding wild-type genomes. As predicted, in the simulated datasets, reads mapped to the known hydrogenases were significantly more abundant in the hydrogenase-containing dataset than in the hydrogenase-free dataset. However, 21 HydDB entries (out of 3,248) had more than 2-fold enrichment of reads that mapped to the hydrogenase-free dataset than in the hydrogenase-containing dataset. This data suggested that those 21 HydDB entries</p><p>may be incorrectly annotated or may share too high of homology with non-hydrogenase sequences of the representative gut microbiome genomes to be reliably annotated as hydrogenases in our study. These 21 HydDB entries were therefore removed from our analyses. We have updated the results and methods section of the revised manuscript to reflect these additional details.</p><p>Additionally, we have used Bonferroni correction to adjust for multiple hypothesis testing in our comparisons between hydrogenase activities. The new data and statistical analyses are presented in Figure 1A-C of the revised manuscript. Following exclusion of potentially incorrectly annotated hydrogenases and Bonferroni correction of the statistical analyses, the relative abundance of reads mapping to predicted uptake hydrogenases are still significantly higher in DSS-treated murine samples and human IBD patient samples than in the respective control samples. As such, these data support our interpretation that microbial H<sub>2</sub> metabolism is altered during intestinal inflammation and that uptake hydrogenases may contribute to microbial fitness in the inflamed gut.</p><p>The reviewers raised a valid concern regarding our initial interpretation of the enrichment of <italic>Enterobacteriaceae</italic> hydrogenases in the metagenomic datasets, given the increase in <italic>Enterobacteriaceae</italic> known to occur during intestinal inflammation (Haberman et al., 2014; Kotlowski et al., 2007; Lupp et al., 2007). Therefore, we have chosen to remove the mapping of metagenomic sequencing reads to <italic>Enterobacteriaceae hya</italic> and <italic>hyb</italic> operons from the manuscript.</p><disp-quote content-type="editor-comment"><p>2. Another major issue in my opinion is the conceptual framing around &quot;dysbiosis&quot;, which is a problematic term due to its inconsistent use in the scientific literature but nonetheless implies some sort of overall shift in gut microbial community structure. That isn't really tested here, all of the experiments show competitive growth between artificial mutants and wild-type <italic>E. coli</italic>. There's also only a single experiment (Figure 4) that include healthy controls, making it impossible to determine if the expansion of <italic>E. coli</italic> is impacted by the loss of hya and/or hyb. Figure 4c,d shows that the double KO is still able to expand in DSS treated mice, conflicting with the hypothesis that hydrogen metabolism is required for dysbiosis. On a related note, the authors should discuss the alternative hypothesis that dysbiosis occurs prior to colitis. The assumption herein is that inflammation drives a shift in the microenvironment's redox potential which then shifts the gut microbiota. More citations are needed to explain the rationale and current evidence in support of these two alternative hypotheses in humans and mouse models. One simple experiment that could be done to address the author's dysbiosis hypothesis would be to colonize mice with a single strain at a time. Can the double KO still expand in the absence of wild-type? Does it reach a lower abundance than wild-type in mono-colonization?</p></disp-quote><p>The reviewers raised important points regarding the use of the term “dysbiosis”. Generally, it describes changes in the composition and/or function and/or location of microbial communities during disease. In our study, we only carefully investigated <italic>E. coli</italic> metabolism in the context of inflammation, as the reviewer pointed out. We have therefore rephrased the title, parts of the abstract, and parts of the introduction, making a careful distinction between disease-associated microbiota changes and expansion of <italic>Enterobacteriaceae</italic> family members such as <italic>E. coli</italic> during inflammatory flares. The new title reads “Reshaping of bacterial molecular hydrogen metabolism contributes to the outgrowth of commensal <italic>E. coli</italic> during gut inflammation”.</p><p>As the reviewers have mentioned, it is unclear whether microbiota changes occur as a consequence of colitis or vice versa. Current evidence in the literature supports both hypotheses, which are of course not mutually exclusive (Chanin et al., 2020; David et al., 2014; Garrett et al., 2007; Moayyedi et al., 2015; Seregin et al., 2017; Winter et al., 2013; Zhu et al., 2018). As recommended by the reviewers, we have updated the introduction to include additional citations and a statement of hypotheses regarding the order of occurrence of “dysbiosis” and colitis. Of note, these various hypotheses highlight the need for additional studies of the mechanisms responsible for microbiota changes during inflammation and its impact on host physiology.</p><p>The reviewers make a valid point that additional competitive growth experiments in healthy animals would provide strong support for the role of inflammation in hydrogen-dependent outgrowth of <italic>Enterobacteriaceae</italic>. To address this concern, we performed three experiments.</p><p>1. We assessed the fitness of the wild-type strain compared to the hydrogenase-deficient strain in a time-course experiment (Figure 5). The fitness advantage conferred by hydrogen utilization developed with the onset of inflammation (Figure 5) and correlated with colon length, a sensitive marker of inflammation (Figure 5—figure supplement 3).</p><p>2. Experimentally introduced <italic>E. coli</italic> colonizes healthy animals inconsistently<italic>,</italic> making such studies challenging since, at later time points, few animals are colonized by <italic>E. coli</italic>. We therefore colonized healthy animals with our wild-type and hydrogenase-deficient strains for a short period of time (3 days) and recovered both strains in most animals . In the absence of inflammation, we observed similar levels of colonization by the wild-type and hydrogenase-deficient strain in these animals. This new data is included in Figure 5—figure supplement 4 of the revised manuscript.</p><p>3. We colonized mice with a single strain at a time, as suggested by the reviewers, to determine whether the fitness advantage conferred by hydrogen utilization contributes to colonization of the murine gut. We observed that the hydrogenase-deficient strain colonized DSS-treated mice to a lower level than the wild-type strain, providing further support for the idea that hydrogen utilization contributes to the outgrowth by <italic>E. coli</italic> during colitis. This new data is in Figure 3 of the revised manuscript.</p><disp-quote content-type="editor-comment"><p>3. While the genetics shows that this operon matters in vivo, there's no real data supporting whether or not hydrogenase activity is responsible, either in vitro or in vivo. Ideally additional assays and/or experiments could be added to provide support for the metabolic consequences of these deletions. At a minimum, this caveat needs to be added to the discussion and the authors should be careful not to imply that the activity matters (just that the operons do). Key controls are also missing for the bacterial genetics, including comparisons of the KO and wild-type strains during in vitro growth and complementation.</p></disp-quote><p>We have analyzed growth of our <italic>E. coli</italic> strains under defined laboratory conditions, as suggested. Growth of the wild-type strain and hydrogenase-deficient strains under atmospheric air conditions is virtually identical (Figure 2—figure supplement 1A), suggesting that the lack of Hyd-1/2 hydrogenase activity does not impede growth non-specifically. Consistent with previous findings (Laurinavichene and Tsygankov, 2001; Yamamoto and Ishimoto, 1978), we noted that hydrogen utilization enhanced growth under anaerobic conditions in the presence of fumarate and nitrate as the exogenous electron acceptors (Figure 2—figure supplement 1B). The phenotype in vitro is solely due to Hyd-2 activity (Figure 2—figure supplement 1B). Genetic complementation of the Hyd-2-deficient strain (native promoter and coding sequences on a low-copy number plasmid) rescues the fitness phenotype (Figure 2—figure supplement 1C). Unfortunately, we were unable to establish a phenotype in vitro for Hyd-1, presumably due to inadequate modeling of the mouse intestinal tract in vitro (Figure 2—figure supplement 1B). We have therefore edited the text to discuss the caveat that our study does not analyze the activity of Hyd-1 in vitro.</p><disp-quote content-type="editor-comment"><p>4. There is little insight into how mechanistically these hydrogenases may provide a growth advantage in the intestine, and specifically what it is about inflammation that makes Hyd-1 and Hyd-2 important? For example, how does DSS-induced weight loss change in Enterobacteriaceae-free (Jax B6) mice vs. those colonized with MP1 or EcN strains of <italic>E. coli</italic>? One might infer that EcN induces less inflammation than MP1, based upon Figure 2B vs. D, but there is no control group without <italic>E. coli</italic> to compare to. This leads me to the next example, which is Figure 5 piroxican Il10-/- experiments. Although the body weight of Il10-/- BALB/c mice on piroxicam is only minimally reduced (indicating less inflammation) compared to the Il10-/- C57BL/6 model, the EcN and MP1 bloom is still statistically significant. It is an oversimplification to conclude that Hyd-1 and Hyd-2 are important during &quot;inflammation,&quot; as weight loss is the only measure of inflammation and differs between mouse strains and models. I recommend additional controls for each of these models, including DSS or piroxicam with no <italic>E. coli</italic> colonization, and knockout strains evaluated in the presence and absence of inflammation (i.e. no DSS to demonstrate Hyd-1 and Hyd-2 are not important under homeostatic conditions). Furthermore, there should be greater analysis into what aspect of inflammation makes Hyd-1 and Hyd-2 important for bacterial bloom – is there a direct correlation between extent of weight loss? Is there an immune cell type, cytokine signature, or histologic feature that makes Hyd-1 and Hyd-2 important? The spread of data in Figure 5 shows it would be possible to tease this apart.</p></disp-quote><p>As suggested, we analyzed what specifically about inflammation facilitates <italic>E. coli</italic> outgrowth via Hyd-1 and Hyd-2. Hyd-1 and Hyd-2 oxidize H<sub>2</sub>, thus providing electrons that can be used in <italic>E. coli</italic>’s electron transport chain. For example, hydrogen oxidation can be coupled to fumarate or nitrate respiration in vitro, with nitrate being the preferred electron acceptor due to its more favorable redox potential (Figure 7A). During intestinal inflammation, electron donors such as nitrate and oxygen become available. Nitrate is generated through the decay of reactive nitrogen species. Oxygen tension in the gut lumen is increased as a result of diffusion of oxygen from the vasculature into the lumen (Cevallos et al., 2019; Chanin et al., 2020; Hughes et al., 2017; Winter et al., 2013). Therefore, we tested whether nitrate reductases or a cytochrome-bd II oxidase facilitate the fitness advantage provided by Hyd-1 and Hyd-2 (Figure 7B, C). The competitive advantage conferred by Hyd-1 and Hyd-2 was significantly reduced in the absence of fumarate reductase, cytochrome bd-II oxidase, or nitrate reductase activity. Consistent with the idea that all three electron acceptors contribute to the hydrogen utilization phenotype, inactivation of each reductase did not completely abolish the phenotype. We therefore conclude that the change in availability of electron acceptors during intestinal inflammation may be a driver for hydrogenase-dependent outgrowth of <italic>E. coli</italic>. Of note, this new data does not exclude the possibility that disruptions in microbe-microbe H<sub>2</sub> exchange between other commensal microbes may also contribute to the utility of Hyd-1 and Hyd-2 during colitis. This new data is presented in Figure 7A-C and we have updated the results and discussion.</p><p>The reviewers raised the point that our study focused primarily on body weights as a metric for intestinal inflammation. We performed a time-course experiment to address the concerns raised in major points #2 and #4, regarding our interpretation that hydrogenases provided a fitness advantage in the context of inflammation. In addition to assessing changes in body weight in this experiment, we also measured colon lengths, assessed mRNA levels of markers of inflammation in colonic and cecal tissue, and assessed inflammation in a semi-quantitative manner by histology (Figure 5—figure supplements 1 and 2). Histopathology analysis was also performed on another key experiment in the original manuscript during which competitive indices were compared between mock- and DSS- treated animals. The new data is shown in Figures 4C and Figure 5—figure supplement 1-2.</p><p>The reviewers asked whether there are differences in disease outcome between <italic>Enterobacteriaceae</italic>-free animals and those colonized with various <italic>E. coli</italic> strains. The literature suggests <italic>Enterobacteriaceae</italic> worsen disease outcome in animal models of IBD (Chassaing et al., 2014; Ellermann et al., 2019; Garrett et al., 2010; Zhu et al., 2018), but further mechanistic studies are needed. However, our current study does not attempt to answer such questions, and we have clarified the introduction to avoid any confusion.</p><disp-quote content-type="editor-comment"><p>5. Male and female mice were used in these experiments. DSS has a known sex difference. The authors must indicate the sex of the mice and test to see if sex could be responsible for the observed changes.</p></disp-quote><p>We agree with the reviewers that sex should be considered in this study. We have updated the manuscript figure legends to include what sexes were used. We repeated various experiments from the original manuscript with more female and/or male mice. We did not observe a contribution of mouse sex to the competitive advantage of the wild-type strain compared to the mutant strain lacking <italic>hya</italic> and <italic>hyb</italic>, which stratifies the data from Figure 7B-C in the revised manuscript (WT vs <italic>hya hyb</italic>) by mouse sex. No statistically significant differences in the magnitude of the phenotype were noted. We have included this data in Figure 7—figure supplement 1 in the revised manuscript.</p></body></sub-article></article>